---
arturl_encode: "68747470733a2f2f626c6f672e:6373646e2e6e65742f77656978696e5f33383539343637362f:61727469636c652f64657461696c732f313436323631383738"
layout: post
title: "èƒ¶è´¨æ¯ç»†èƒç˜¤æµ¸æ¶¦çš„ä¸ªæ€§åŒ–é¢„æµ‹æ•°å­¦æ¨¡å‹åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œä»¥åŠå¤šæ¨¡æ€æ‰«ææ–‡çŒ®é€Ÿé€’-åŒ»å­¦å½±åƒäººå·¥æ™ºèƒ½è¿›å±•"
date: 2025-03-14 17:06:37 +08:00
description: "Titleé¢˜ç›®Personalized predictions of Glioblastoma infiltration: Mathematical models,Physics-Informed Neural Networks and multimodal scansèƒ¶è´¨æ¯ç»†èƒç˜¤æµ¸æ¶¦çš„ä¸ªæ€§åŒ–é¢„æµ‹ï¼šæ•°å­¦æ¨¡å‹ã€åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œä»¥åŠå¤šæ¨¡æ€æ‰«æ01æ–‡çŒ®é€Ÿé€’ä»‹ç»èƒ¶è´¨æ¯ç»†èƒç˜¤ï¼ˆGBMï¼‰æ˜¯ä¸€ç§å¸¸è§ä¸”æå…·ä¾µè¢­æ€§çš„è„‘è‚¿ç˜¤ï¼Œä¸­ä½ç”Ÿå­˜æœŸä¸º15ä¸ªæœˆï¼ˆæ–¯å›¾æ™®ç­‰äººï¼Œ2014å¹´ï¼Œ2005å¹´ï¼‰ã€‚ç›®å‰èƒ¶è´¨æ¯ç»†èƒç˜¤çš„æ ‡å‡†æ²»ç–—æ–¹æ¡ˆåŒ…æ‹¬åœ¨"
keywords: "èƒ¶è´¨æ¯ç»†èƒç˜¤æµ¸æ¶¦çš„ä¸ªæ€§åŒ–é¢„æµ‹ï¼šæ•°å­¦æ¨¡å‹ã€åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œä»¥åŠå¤šæ¨¡æ€æ‰«æ|æ–‡çŒ®é€Ÿé€’-åŒ»å­¦å½±åƒäººå·¥æ™ºèƒ½è¿›å±•"
categories: ['æœªåˆ†ç±»']
tags: ['æ•°å­¦å»ºæ¨¡']
artid: "146261878"
image:
    path: https://api.vvhan.com/api/bing?rand=sj&artid=146261878
    alt: "èƒ¶è´¨æ¯ç»†èƒç˜¤æµ¸æ¶¦çš„ä¸ªæ€§åŒ–é¢„æµ‹æ•°å­¦æ¨¡å‹åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œä»¥åŠå¤šæ¨¡æ€æ‰«ææ–‡çŒ®é€Ÿé€’-åŒ»å­¦å½±åƒäººå·¥æ™ºèƒ½è¿›å±•"
render_with_liquid: false
featuredImage: https://bing.ee123.net/img/rand?artid=146261878
featuredImagePreview: https://bing.ee123.net/img/rand?artid=146261878
cover: https://bing.ee123.net/img/rand?artid=146261878
image: https://bing.ee123.net/img/rand?artid=146261878
img: https://bing.ee123.net/img/rand?artid=146261878
---

# èƒ¶è´¨æ¯ç»†èƒç˜¤æµ¸æ¶¦çš„ä¸ªæ€§åŒ–é¢„æµ‹ï¼šæ•°å­¦æ¨¡å‹ã€åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œä»¥åŠå¤šæ¨¡æ€æ‰«æ|æ–‡çŒ®é€Ÿé€’-åŒ»å­¦å½±åƒäººå·¥æ™ºèƒ½è¿›å±•

## 

**Title**

**é¢˜ç›®**

*Personalized predictions of Glioblastoma infiltration: Mathematical models,Physics-Informed Neural Networks and multimodal scans*

èƒ¶è´¨æ¯ç»†èƒç˜¤æµ¸æ¶¦çš„ä¸ªæ€§åŒ–é¢„æµ‹ï¼šæ•°å­¦æ¨¡å‹ã€åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œä»¥åŠå¤šæ¨¡æ€æ‰«æ

**01**

**æ–‡çŒ®é€Ÿé€’ä»‹ç»**

èƒ¶è´¨æ¯ç»†èƒç˜¤ï¼ˆGBMï¼‰æ˜¯ä¸€ç§å¸¸è§ä¸”æå…·ä¾µè¢­æ€§çš„è„‘è‚¿ç˜¤ï¼Œä¸­ä½ç”Ÿå­˜æœŸä¸º15ä¸ªæœˆï¼ˆæ–¯å›¾æ™®ç­‰äººï¼Œ2014å¹´ï¼Œ2005å¹´ï¼‰ã€‚ç›®å‰èƒ¶è´¨æ¯ç»†èƒç˜¤çš„æ ‡å‡†æ²»ç–—æ–¹æ¡ˆåŒ…æ‹¬åœ¨ç¡®è¯Šåç«‹å³åˆ‡é™¤å¯è§è‚¿ç˜¤ï¼Œéšåé’ˆå¯¹æ®‹ç•™è‚¿ç˜¤è¿›è¡Œæ”¾ç–—å’ŒåŒ–ç–—ï¼ˆè´¹å°”å—å¾·æ–¯ç­‰äººï¼Œ2017å¹´ï¼‰ã€‚å°½ç®¡è¿›è¡Œäº†å¼ºåŒ–æ²»ç–—ï¼Œä½†èƒ¶è´¨æ¯ç»†èƒç˜¤çš„é¢„åä»ç„¶å¾ˆå·®ï¼Œå› ä¸ºå‡ ä¹æ‰€æœ‰çš„èƒ¶è´¨æ¯ç»†èƒç˜¤éƒ½ä¼šå¤å‘ã€‚èƒ¶è´¨æ¯ç»†èƒç˜¤çš„é«˜å¤å‘ç‡å½’å› äºå…¶æµ¸æ¶¦æ€§ã€‚è‚¿ç˜¤å¹¶éå½¢æˆæ¸…æ™°çš„è¾¹ç•Œï¼Œè€Œæ˜¯ä¾µå…¥å‘¨å›´çœ‹ä¼¼æ­£å¸¸çš„è„‘ç»„ç»‡ï¼ˆè‹å“ˆç±³ç­‰äººï¼Œ2004å¹´ï¼›å“ˆå°”ä½©æ—ç­‰äººï¼Œ1989å¹´ï¼‰ã€‚è‚¿ç˜¤ç»†èƒçš„æµ¸æ¶¦æ¨¡å¼æ˜¯å¼‚è´¨æ€§çš„ï¼Œå¹¶ä¸”åœ¨ä¸åŒæ‚£è€…ä¹‹é—´å·®å¼‚å¾ˆå¤§ã€‚å› æ­¤ï¼Œä»å¯è§è‚¿ç˜¤å‡åŒ€å‘å¤–æ‰©å±•1.5-3å˜ç±³çš„æ ‡å‡†ä¸´åºŠæ”¾ç–—é¶åŒºï¼ˆCTVï¼‰ï¼Œå¯èƒ½ä¸è¶³ä»¥å®ç°æœ€ä½³çš„è¦†ç›–å’Œåˆ†å¸ƒï¼ˆæ–¯å›¾æ™®ç­‰äººï¼Œ2005å¹´ï¼‰ã€‚ æé«˜æ”¾ç–—æ²»ç–—è®¡åˆ’çš„ä¸€ä¸ªå…³é”®æ­¥éª¤ï¼Œæ˜¯éœ€è¦ä»¥æ•°æ®é©±åŠ¨ä¸”é’ˆå¯¹ç‰¹å®šæ‚£è€…çš„æ–¹å¼æ¥ä¼°è®¡è‚¿ç˜¤ç»†èƒçš„åˆ†å¸ƒï¼ˆåˆ©æ™®ç§‘å¨ƒç­‰äººï¼Œ2019å¹´ï¼›æ˜‚å…‹å°”å·´èµ«ç­‰äººï¼Œ2014å¹´ï¼›ç½—å…‹å°¼ç­‰äººï¼Œ2010å¹´ã€2015å¹´ã€2019å¹´ï¼‰ã€‚ è‚¿ç˜¤ç”Ÿé•¿çš„æ•°å­¦æ¨¡å‹æœ‰åŠ©äºé¢„æµ‹è‚¿ç˜¤çš„è¿›å±•ï¼Œå¹¶ä¸ºæ‚£è€…çš„ä¸ªæ€§åŒ–æ²»ç–—å†³ç­–æä¾›æŒ‡å¯¼ï¼ˆé²å¤šå…‹ç­‰äººï¼Œ2013å¹´ï¼›åˆ©æ™®ç§‘å¨ƒç­‰äººï¼Œ2019å¹´ï¼›å¸ƒç‰¹çº³ç­‰äººï¼Œ2022å¹´ï¼›å¶è‹¥å¤«ç­‰äººï¼Œ2023å¹´ï¼›ä¹”æœé‡Œç­‰äººï¼Œ2023å¹´ï¼›è‹å¸ƒæ‹‰é©¬å°¼äºšå§†ç­‰äººï¼Œ2023å¹´ï¼›æ´›ä¼¦ä½ç­‰äººï¼Œ2023å¹´ï¼›å´ç­‰äººï¼Œ2022å¹´ï¼‰ã€‚èƒ¶è´¨æ¯ç»†èƒç˜¤çš„ç”Ÿé•¿é€šå¸¸ä½¿ç”¨ååº”-æ‰©æ•£ç±»å‹çš„åå¾®åˆ†æ–¹ç¨‹ï¼ˆPDEï¼‰æ¥å»ºæ¨¡ï¼Œè¿™äº›æ–¹ç¨‹æè¿°äº†è‚¿ç˜¤ç»†èƒå¯†åº¦çš„æ—¶ç©ºæ¼”å˜ï¼Œå¹¶æ•æ‰äº†è‚¿ç˜¤çš„ä¸»è¦è¡Œä¸ºï¼šå¢æ®–å’Œæµ¸æ¶¦ï¼ˆå“ˆæ³¢å°”å¾·ç­‰äººï¼Œ2007å¹´ï¼‰ã€‚æ›´å…ˆè¿›çš„æ¨¡å‹çº³å…¥äº†å…¶ä»–ç‰¹å¾ï¼ŒåŒ…æ‹¬è´¨é‡æ•ˆåº”ï¼ˆéœè´¾ç­‰äººï¼Œ2007å¹´ï¼›è‹å¸ƒæ‹‰é©¬å°¼äºšå§†ç­‰äººï¼Œ2019å¹´ï¼›åˆ©æ™®ç§‘å¨ƒç­‰äººï¼Œ2022å¹´ï¼‰ã€è¡€ç®¡ç”Ÿæˆï¼ˆéº¦å…‹æ—ç­‰äººï¼Œ2009å¹´ï¼›ç´¢ç‰¹ç­‰äººï¼Œ2014å¹´ï¼›ä¸¥ç­‰äººï¼Œ2017å¹´ï¼‰ã€è¶‹åŒ–æ€§ï¼ˆå¢ç­‰äººï¼Œ2022å¹´ã€2023å¹´ï¼‰ä»¥åŠå¤šç§ç»†èƒç±»å‹ï¼ˆæŸ¯å»·ç­‰äººï¼Œ2020å¹´ï¼›ä¸¥ç­‰äººï¼Œ2017å¹´ï¼‰ã€‚å…³äºèƒ¶è´¨æ¯ç»†èƒç˜¤æ•°å­¦å»ºæ¨¡çš„å…¨é¢ç»¼è¿°ï¼Œå¯å‚è§é˜¿æ–¹ç´¢ç­‰äººï¼ˆ2017å¹´ï¼‰ã€æ³•å°”ç§‘ç­‰äººï¼ˆ2021å¹´ï¼‰å’Œçº¦æ ¹æ£®ç­‰äººï¼ˆ2023å¹´ï¼‰çš„ç ”ç©¶ã€‚ ä¸ºäº†åœ¨ä¸´åºŠç¯å¢ƒä¸­åº”ç”¨è¿™äº›æ¨¡å‹ï¼Œå¿…é¡»ä»ä¸´åºŠæ•°æ®ä¸­ä¼°è®¡å‡ºåå¾®åˆ†æ–¹ç¨‹ä¸­é’ˆå¯¹ç‰¹å®šæ‚£è€…çš„å‚æ•°ï¼Œè¿™æ˜¯ä¸€ä¸ªå…·æœ‰æŒ‘æˆ˜æ€§çš„åé—®é¢˜ã€‚é™¤äº†åœ¨æ±‚è§£åå¾®åˆ†æ–¹ç¨‹ä»¥é¢„æµ‹è‚¿ç˜¤ç»†èƒå¯†åº¦åˆ†å¸ƒæ–¹é¢å¾ˆæœ‰ç”¨ä¹‹å¤–ï¼Œè¿™äº›é’ˆå¯¹ç‰¹å®šæ‚£è€…çš„å‚æ•°æœ¬èº«ä½œä¸ºåŸºäºç”Ÿç‰©ç‰©ç†å­¦çš„ç‰¹å¾ï¼Œå¯¹äºæ”¹å–„æ‚£è€…åˆ†å±‚å’Œç”Ÿå­˜é¢„æµ‹ä¹Ÿå¾ˆæœ‰ä»·å€¼ã€‚ä¾‹å¦‚ï¼Œæœ€è¿‘çš„ç ”ç©¶è¡¨æ˜ï¼Œä¸å›¾åƒä¸­çš„ä½“ç§¯ç‰¹å¾ç›¸æ¯”ï¼Œè¿™äº›ç”Ÿç‰©ç‰©ç†ç‰¹å¾ä¸ç”Ÿå­˜æ—¶é—´çš„ç›¸å…³æ€§æ›´å¥½ï¼ˆè‹å¸ƒæ‹‰é©¬å°¼äºšå§†ç­‰äººï¼Œ2023å¹´ï¼‰ã€‚æ­¤å¤–ï¼Œå¢æ®–é€Ÿç‡ä¸æ‰©æ•£é€Ÿç‡çš„æ¯”ç‡ï¼Œæ˜¯è¯„ä¼°IDHé‡ç”Ÿå‹èƒ¶è´¨æ¯ç»†èƒç˜¤æ‚£è€…è¶…è¾¹ç¼˜åˆ‡é™¤æœ‰æ•ˆæ€§çš„å…³é”®ï¼ˆç‰¹é‡Œå¸•è’‚ç­‰äººï¼Œ2021å¹´ï¼‰ã€‚ è¿™ä¸ªåé—®é¢˜é€šå¸¸åœ¨åå¾®åˆ†æ–¹ç¨‹çº¦æŸä¼˜åŒ–çš„æ¡†æ¶å†…æ±‚è§£ï¼ˆèŠ’æ ¼ç­‰äººï¼Œ2012å¹´ï¼›éœè´¾ç­‰äººï¼Œ2008å¹´ï¼›èˆè´¹å‹’ç­‰äººï¼Œ2020å¹´ã€2021å¹´ï¼›è‹å¸ƒæ‹‰é©¬å°¼äºšå§†ç­‰äººï¼Œ2020bã€aï¼Œ2023å¹´ï¼‰ï¼Œæˆ–è€…é€šè¿‡è´å¶æ–¯æ¨ç†æ¥è§£å†³ï¼ˆé—¨æ³½ç­‰äººï¼Œ2011å¹´ï¼›åˆ©æ™®ç§‘å¨ƒç­‰äººï¼Œ2019å¹´ï¼›å¶è‹¥å¤«ç­‰äººï¼Œ2019å¹´ã€2022aï¼‰ã€‚æœºå™¨å­¦ä¹ æ–¹æ³•ä¹Ÿè¢«ç”¨äºåŠ å¿«è®¡ç®—é€Ÿåº¦ï¼ŒåŒ…æ‹¬å­¦ä¹ æ­£å‘åå¾®åˆ†æ–¹ç¨‹ç³»ç»Ÿçš„æ›¿ä»£æ¨¡å‹ï¼ˆå¶è‹¥å¤«ç­‰äººï¼Œ2022aï¼‰ã€ç›´æ¥å­¦ä¹ ä»è§‚æµ‹æ•°æ®åˆ°å‚æ•°çš„æ˜ å°„ï¼ˆå¸•è’‚ç­‰äººï¼Œ2021å¹´ï¼›å¶è‹¥å¤«ç­‰äººï¼Œ2023å¹´ï¼›é©¬æ»•æ–¯ç­‰äººï¼Œ2022å¹´ï¼‰ã€ä½¿ç”¨åŠ¨æ€æ¨¡å¼åˆ†è§£æ¥æ„å»ºä½ç»´è¡¨ç¤ºï¼ˆç»´ç›–é‡Œç­‰äººï¼Œ2022å¹´ï¼‰ï¼Œä»¥åŠä½¿ç”¨åŸºäºç½‘æ ¼çš„ç¦»æ•£åŒ–æ–¹æ³•æ¥ä¼˜åŒ–æ•´åˆäº†åå¾®åˆ†æ–¹ç¨‹å’Œæ•°æ®çš„ç¦»æ•£æŸå¤±æ¡†æ¶ï¼ˆå¡å°”çº³ç§‘å¤«ç­‰äººï¼Œ2022å¹´ï¼›å·´å°”é‡‡æ‹‰å…‹ç­‰äººï¼Œ2024aï¼‰ã€‚é™¤äº†å®Œæ•´çš„ååº”-æ‰©æ•£æ¨¡å‹ï¼Œè¿˜å¯ä»¥åˆ©ç”¨å…¶æ¸è¿‘æ€§è´¨æ¥è·å¾—è¿‘ä¼¼çš„å„å‘å¼‚æ€§ç¨‹å‡½è¿‘ä¼¼ï¼Œè¿™ç®€åŒ–äº†å‚æ•°ä¼°è®¡å’Œè‚¿ç˜¤ç»†èƒå¯†åº¦é¢„æµ‹ï¼Œå°½ç®¡æ¨¡å‹çš„ç»†èŠ‚è¾ƒå°‘ï¼ˆç§‘åŠªç§‘æ ¼é²ç­‰äººï¼Œ2010aã€bï¼›æ˜‚å…‹å°”å·´èµ«ç­‰äººï¼Œ2014å¹´ï¼‰ã€‚ åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œï¼ˆPINNsï¼‰å·²ç»æˆä¸ºä¸€ç§åœ¨åå¾®åˆ†æ–¹ç¨‹çº¦æŸä¼˜åŒ–æ¡†æ¶å†…è§£å†³åé—®é¢˜çš„æ–°æ–¹æ³•ï¼ˆå¡å°”å°¼äºšè¾¾åŸºæ–¯ç­‰äººï¼Œ2021å¹´ï¼›æ‹‰ä¼Šè¥¿ç­‰äººï¼Œ2019å¹´ï¼›è´¾æ ¼å¡”æ™®ç­‰äººï¼Œ2022aã€bï¼›é™ˆç­‰äººï¼Œ2020å¹´ï¼›éƒ‘ç­‰äººï¼Œ2023å¹´ï¼›é»„ç­‰äººï¼Œ2022å¹´ï¼‰ã€‚åœ¨è¿™ç§æ–¹æ³•ä¸­ï¼ŒåŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œå°†åå¾®åˆ†æ–¹ç¨‹çš„è§£è¡¨ç¤ºä¸ºä¸€ä¸ªç¥ç»ç½‘ç»œï¼Œå¹¶é€šè¿‡æ— ç½‘æ ¼æ–¹æ³•ï¼ˆä½¿ç”¨è‡ªåŠ¨å¾®åˆ†ï¼‰å°†æ•°æ®å’Œåå¾®åˆ†æ–¹ç¨‹éƒ½åµŒå…¥åˆ°æŸå¤±å‡½æ•°ä¸­ã€‚é€šè¿‡æœ€å°åŒ–æ€»æŸå¤±ï¼ŒåŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œå¯ä»¥æœ‰æ•ˆåœ°åŒæ—¶æ±‚è§£åå¾®åˆ†æ–¹ç¨‹å¹¶æ‹Ÿåˆæ•°æ®ï¼Œå±•ç¤ºäº†æ•°å­¦æ¨¡å‹ä¸æ•°æ®é©±åŠ¨å­¦ä¹ è¿‡ç¨‹çš„æ•´åˆã€‚è¿™åœ¨åŒ»å­¦å›¾åƒåˆ†æé¢†åŸŸå°¤å…¶æœ‰ç›Šï¼Œå› ä¸ºä¸´åºŠæµ‹é‡æ•°æ®å¾€å¾€ç¨€ç–ä¸”è·å–æˆæœ¬é«˜æ˜‚ã€‚åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œå·²è¢«ç”¨äºç»“åˆç»é¢…å¤šæ™®å‹’æµ‹é‡çš„è¡€æµé€Ÿåº¦æ•°æ®ï¼Œä»¥åŠæ§åˆ¶æµé€Ÿã€å‹åŠ›å’Œè¡€ç®¡é¢ç§¯çš„åå¾®åˆ†æ–¹ç¨‹ï¼Œæ¥ä¼°è®¡è„‘è¡€æµåŠ¨åŠ›å­¦ï¼ˆè¨æ‹‰æ¯”å®‰ç­‰äººï¼Œ2022å¹´ï¼‰ã€‚åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œè¿˜è¢«ç”¨äºåˆ©ç”¨çŒæ³¨ç£å…±æŒ¯æ•°æ®æ ¡å‡†ç¤ºè¸ªå‰‚åŠ¨åŠ›å­¦æ¨¡å‹ä¸­çš„å‚æ•°ï¼Œä»¥é‡åŒ–å¿ƒè‚Œè¡€æµé‡ï¼ˆèŒƒèµ«æ»•ç­‰äººï¼Œ2022å¹´ï¼‰ã€‚æœ±ï¼ˆ2022å¹´ï¼‰åˆ©ç”¨åˆæˆç»†èƒå¯†åº¦æ•°æ®æ¢ç´¢äº†åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œè§£å†³èƒ¶è´¨æ¯ç»†èƒç˜¤åé—®é¢˜çš„æ½œåŠ›ã€‚ åœ¨è¿™é¡¹å·¥ä½œä¸­ï¼Œæˆ‘ä»¬é€šè¿‡ä½¿ç”¨ååº”-æ‰©æ•£åå¾®åˆ†æ–¹ç¨‹æ¨¡å‹çš„è§£ï¼Œå¯¹åŒ»å­¦æ‰«æä¸­å¯è§è‚¿ç˜¤å›¢å—ä¹‹å¤–çš„èƒ¶è´¨æ¯ç»†èƒç˜¤è‚¿ç˜¤ç»†èƒå¯†åº¦åˆ†å¸ƒè¿›è¡Œä¸ªæ€§åŒ–é¢„æµ‹ï¼Œæ¨¡å‹å‚æ•°é€šè¿‡å•ä¸ªæ—¶é—´ç‚¹çš„ä¸‰ç»´ç»“æ„MRIå¿«ç…§æ¥ä¼°è®¡ã€‚å›¾1æ¦‚è¿°äº†æˆ‘ä»¬çš„æ–¹æ³•ã€‚æˆ‘ä»¬çš„æ•°æ®åŒ…æ‹¬T1é’†å¢å¼ºï¼ˆT1Gdï¼‰å’Œæ¶²ä½“è¡°å‡åè½¬æ¢å¤ï¼ˆFLAIRï¼‰MRIæ‰«æçš„å•ä¸ªå¿«ç…§ã€‚æˆ‘ä»¬å°†åå¾®åˆ†æ–¹ç¨‹æ¨¡å‹ä¸ä¸€ä¸ªå›¾åƒæ¨¡å‹ç›¸ç»“åˆï¼Œè¯¥å›¾åƒæ¨¡å‹é€šè¿‡é˜ˆå€¼å¤„ç†å°†åˆ†å‰²ç»“æœä¸è‚¿ç˜¤ç»†èƒå¯†åº¦è”ç³»èµ·æ¥ã€‚æˆ‘ä»¬é€šè¿‡è¯†åˆ«ä¸æ—¶é—´æ— å…³çš„å‚æ•°ã€å¯¹æ¨¡å‹è¿›è¡Œé€‚å½“çš„æ— é‡çº²åŒ–å¤„ç†ä»¥åŠæ¨æ–­æ— é‡çº²å‚æ•°ï¼Œå…‹æœäº†ä½¿ç”¨å•ä¸ªæ—¶é—´ç‚¹æ•°æ®æ¨æ–­å‚æ•°çš„æŒ‘æˆ˜ã€‚æˆ‘ä»¬ä½¿ç”¨åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œæ¥æ±‚è§£åå¾®åˆ†æ–¹ç¨‹ï¼Œå¹¶ä»æ•°æ®ä¸­ä¼°è®¡å‚æ•°ã€‚ä¼°è®¡å‡ºçš„å‚æ•°ç”¨äºé¢„æµ‹è‚¿ç˜¤ç»†èƒå¯†åº¦ï¼Œå¹¶è¾…åŠ©ä¸ªæ€§åŒ–æ”¾ç–—æ²»ç–—è®¡åˆ’çš„åˆ¶å®šã€‚æˆ‘ä»¬åœ¨åˆæˆæ•°æ®å’Œæ‚£è€…æ•°æ®ä¸ŠéªŒè¯äº†æˆ‘ä»¬çš„æ–¹æ³•ï¼Œåœ¨è¿™äº›æ•°æ®ä¸Šæˆ‘ä»¬å¯ä»¥è®¡ç®—è¯¸å¦‚åˆ†å‰²çš„DICEç³»æ•°ç­‰å®šé‡æŒ‡æ ‡ï¼Œå¹¶å°†é¢„æµ‹çš„æµ¸æ¶¦æ¨¡å¼ä¸è§‚å¯Ÿåˆ°çš„è‚¿ç˜¤å¤å‘æƒ…å†µè¿›è¡Œæ¯”è¾ƒã€‚ è´¡çŒ®ï¼šæˆ‘ä»¬çš„è´¡çŒ®å¦‚ä¸‹ï¼šï¼ˆ1ï¼‰æˆ‘ä»¬è¯æ˜äº†åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œæ˜¯ä¸€ç§æœ‰æ•ˆä¸”é«˜æ•ˆçš„æ–¹æ³•ï¼Œå¯åˆ©ç”¨å•ä¸ªæ—¶é—´ç‚¹çš„ç»“æ„MRIæ•°æ®ï¼ˆè¿™æ˜¯æœ€å¸¸è§çš„å¯ç”¨ä¸´åºŠæ•°æ®ï¼‰æ¥è§£å†³èƒ¶è´¨æ¯ç»†èƒç˜¤ä¸­åå¾®åˆ†æ–¹ç¨‹å‚æ•°ä¼°è®¡çš„åé—®é¢˜ã€‚ï¼ˆ2ï¼‰å¼•å…¥äº†ä¸€ä¸ªç®€å•çš„ç¨‹åºæ¥ä¼°è®¡é’ˆå¯¹ç‰¹å®šæ‚£è€…çš„æ— é‡çº²ç‰¹å¾å‚æ•°ï¼Œè¿™æœ‰åŠ©äºå¯¹åå¾®åˆ†æ–¹ç¨‹è¿›è¡Œç¼©æ”¾ï¼Œä»¥è§£å†³å•æ—¶é—´ç‚¹æ¨æ–­çš„å±€é™æ€§ã€‚ï¼ˆ3ï¼‰æˆ‘ä»¬æå‡ºäº†ä¸€ä¸ªæœ‰æ•ˆçš„ä¸¤æ­¥è®­ç»ƒç¨‹åºï¼šåœ¨é¢„è®­ç»ƒæ­¥éª¤ä¸­ï¼Œæˆ‘ä»¬åˆ©ç”¨é’ˆå¯¹ç‰¹å®šæ‚£è€…çš„æ— é‡çº²ç‰¹å¾å‚æ•°æ¥è®­ç»ƒåŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œï¼Œä»¥å­¦ä¹ åå¾®åˆ†æ–¹ç¨‹çš„ç‰¹å¾è§£ã€‚è¿™ä¸ºå¾®è°ƒé˜¶æ®µæä¾›äº†ä¸€ä¸ªå¾ˆå¥½çš„èµ·ç‚¹ï¼Œåœ¨å¾®è°ƒé˜¶æ®µæˆ‘ä»¬è®­ç»ƒåŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œæ¥å­¦ä¹ é’ˆå¯¹ç‰¹å®šæ‚£è€…çš„å‚æ•°ã€‚ï¼ˆ4ï¼‰æˆ‘ä»¬å¼•å…¥äº†æ‰©æ•£åŸŸæ–¹æ³•ï¼Œä»¥åœ¨åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œæ¡†æ¶å†…å¤„ç†å¤æ‚çš„è„‘éƒ¨å‡ ä½•ç»“æ„ã€‚ å±€é™æ€§ï¼šå½“å‰çš„ç ”ç©¶æ˜¯ä¸€é¡¹æ¦‚å¿µéªŒè¯ç ”ç©¶ï¼Œæ•°æ®æœ‰é™ï¼Œå› ä¸ºè·å–å¤å‘æ•°æ®å…·æœ‰æŒ‘æˆ˜æ€§ã€‚è™½ç„¶æˆ‘ä»¬ç›®å‰çš„æ–¹æ³•åŸºäºä¸€ä¸ªç®€åŒ–æ¨¡å‹ï¼Œä¸”ç¼ºä¹ä¸ç¡®å®šæ€§é‡åŒ–ï¼Œä½†æˆ‘ä»¬çš„æ–¹æ³•åœ¨ä»¥æ•°æ®é©±åŠ¨å’ŒåŸºäºç‰©ç†ä¿¡æ¯çš„æ–¹å¼å¯¹èƒ¶è´¨æ¯ç»†èƒç˜¤çš„æµ¸æ¶¦æ¨¡å¼è¿›è¡Œä¸ªæ€§åŒ–é¢„æµ‹æ–¹é¢æ˜¾ç¤ºå‡ºäº†æ½œåŠ›ã€‚åœ¨3.3èŠ‚ä¸­ï¼Œæˆ‘ä»¬æ›´è¯¦ç»†åœ°è®¨è®ºäº†ä¸å…¶ä»–è®¡ç®—æ–¹æ³•ç›¸æ¯”ï¼Œæˆ‘ä»¬æ–¹æ³•çš„ä¼˜ç‚¹å’Œå±€é™æ€§ã€‚ åœ¨æœ¬æ–‡çš„å…¶ä½™éƒ¨åˆ†ï¼Œç¬¬2èŠ‚é˜è¿°äº†æˆ‘ä»¬æ–¹æ³•çš„å„ä¸ªç»„æˆéƒ¨åˆ†ï¼ŒåŒ…æ‹¬è‚¿ç˜¤ç”Ÿé•¿çš„æ•°å­¦æ¨¡å‹ï¼ˆ2.1èŠ‚ï¼‰ã€å‚æ•°ä¼°è®¡è¿‡ç¨‹çš„å·¥ä½œæµç¨‹ï¼ˆ2.2èŠ‚ï¼‰ä»¥åŠç”¨äºè®­ç»ƒåŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œçš„æŸå¤±å‡½æ•°ï¼ˆ2.3èŠ‚ï¼‰ã€‚ç»“æœåœ¨ç¬¬3èŠ‚ä¸­å‘ˆç°ï¼Œæˆ‘ä»¬é¦–å…ˆåœ¨åˆæˆæ•°æ®ä¸ŠéªŒè¯äº†æˆ‘ä»¬çš„æ–¹æ³•ï¼ˆ3.1èŠ‚ï¼‰ï¼Œç„¶åå°†æˆ‘ä»¬çš„æ–¹æ³•åº”ç”¨äºæ‚£è€…æ•°æ®ï¼ˆ3.2èŠ‚ï¼‰ã€‚åœ¨3.3èŠ‚ä¸­ï¼Œæˆ‘ä»¬è¿˜è®¨è®ºäº†ä¸å…¶ä»–æ–¹æ³•ç›¸æ¯”ï¼Œæˆ‘ä»¬æ–¹æ³•çš„ä¼˜ç‚¹å’Œå±€é™æ€§ã€‚ç»“è®ºåœ¨ç¬¬4èŠ‚ä¸­ç»™å‡ºã€‚æ›´å¤šçš„æŠ€æœ¯ç»†èŠ‚å’Œç»“æœåœ¨é™„å½•ä¸­ç»™å‡ºã€‚

**Aastract**

**æ‘˜è¦**

*Predicting the infiltration of Glioblastoma (GBM) from medical MRI scans is crucial for understanding tumorgrowth dynamics and designing personalized radiotherapy treatment plans. Mathematical models of GBMgrowth can complement the data in the prediction of spatial distributions of tumor cells. However, this requiresestimating patient-specific parameters of the model from clinical data, which is a challenging inverse problemdue to limited temporal data and the limited time between imaging and diagnosis. This work proposes a methodthat uses Physics-Informed Neural Networks (PINNs) to estimate patient-specific parameters of a reactionâ€“diffusion partial differential equation (PDE) model of GBM growth from a single 3D structural MRI snapshot.PINNs embed both the data and the PDE into a loss function, thus integrating theory and data. Key innovationsinclude the identification and estimation of characteristic non-dimensional parameters, a pre-training step thatutilizes the non-dimensional parameters and a fine-tuning step to determine the patient specific parameters.Additionally, the diffuse-domain method is employed to handle the complex brain geometry within the PINNframework. The method is validated on both synthetic and patient datasets, showing promise for personalizedGBM treatment through parametric inference within clinically relevant timeframes.*

ä»åŒ»å­¦ç£å…±æŒ¯æˆåƒï¼ˆMRIï¼‰æ‰«æç»“æœä¸­é¢„æµ‹èƒ¶è´¨æ¯ç»†èƒç˜¤ï¼ˆGBMï¼‰çš„æµ¸æ¶¦æƒ…å†µï¼Œå¯¹äºç†è§£è‚¿ç˜¤çš„ç”Ÿé•¿åŠ¨æ€ä»¥åŠè®¾è®¡ä¸ªæ€§åŒ–çš„æ”¾å°„æ²»ç–—æ–¹æ¡ˆè‡³å…³é‡è¦ã€‚èƒ¶è´¨æ¯ç»†èƒç˜¤ç”Ÿé•¿çš„æ•°å­¦æ¨¡å‹å¯ä»¥åœ¨é¢„æµ‹è‚¿ç˜¤ç»†èƒçš„ç©ºé—´åˆ†å¸ƒæ–¹é¢å¯¹ç›¸å…³æ•°æ®èµ·åˆ°è¡¥å……ä½œç”¨ã€‚ç„¶è€Œï¼Œè¿™éœ€è¦ä»ä¸´åºŠæ•°æ®ä¸­ä¼°è®¡å‡ºé’ˆå¯¹ç‰¹å®šæ‚£è€…çš„æ¨¡å‹å‚æ•°ï¼Œç”±äºæ—¶é—´åºåˆ—æ•°æ®æœ‰é™ï¼Œä»¥åŠæˆåƒå’Œè¯Šæ–­ä¹‹é—´çš„æ—¶é—´é—´éš”æœ‰é™ï¼Œè¿™æ˜¯ä¸€ä¸ªå…·æœ‰æŒ‘æˆ˜æ€§çš„åé—®é¢˜ã€‚ è¿™é¡¹å·¥ä½œæå‡ºäº†ä¸€ç§æ–¹æ³•ï¼Œå³åˆ©ç”¨åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œï¼ˆPINNsï¼‰ï¼Œä»ä¸€å¼ å•ä¸€çš„ä¸‰ç»´ç»“æ„MRIå¿«ç…§ä¸­ï¼Œä¼°è®¡å‡ºæè¿°èƒ¶è´¨æ¯ç»†èƒç˜¤ç”Ÿé•¿çš„ååº”-æ‰©æ•£åå¾®åˆ†æ–¹ç¨‹ï¼ˆPDEï¼‰æ¨¡å‹ä¸­é’ˆå¯¹ç‰¹å®šæ‚£è€…çš„å‚æ•°ã€‚åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œå°†æ•°æ®å’Œåå¾®åˆ†æ–¹ç¨‹éƒ½åµŒå…¥åˆ°æŸå¤±å‡½æ•°ä¸­ï¼Œä»è€Œå°†ç†è®ºä¸æ•°æ®ç»“åˆèµ·æ¥ã€‚ä¸»è¦çš„åˆ›æ–°ç‚¹åŒ…æ‹¬å¯¹ç‰¹å¾æ— é‡çº²å‚æ•°çš„è¯†åˆ«å’Œä¼°è®¡ã€ä¸€ä¸ªåˆ©ç”¨æ— é‡çº²å‚æ•°çš„é¢„è®­ç»ƒæ­¥éª¤ï¼Œä»¥åŠä¸€ä¸ªç”¨äºç¡®å®šç‰¹å®šæ‚£è€…å‚æ•°çš„å¾®è°ƒæ­¥éª¤ã€‚æ­¤å¤–ï¼Œåœ¨åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œæ¡†æ¶å†…ï¼Œé‡‡ç”¨äº†æ‰©æ•£åŸŸæ–¹æ³•æ¥å¤„ç†å¤æ‚çš„è„‘éƒ¨å‡ ä½•ç»“æ„ã€‚ è¯¥æ–¹æ³•åœ¨åˆæˆæ•°æ®é›†å’Œæ‚£è€…æ•°æ®é›†ä¸Šéƒ½è¿›è¡Œäº†éªŒè¯ï¼Œç»“æœè¡¨æ˜ï¼Œé€šè¿‡åœ¨ä¸´åºŠç›¸å…³çš„æ—¶é—´èŒƒå›´å†…è¿›è¡Œå‚æ•°æ¨æ–­ï¼Œè¯¥æ–¹æ³•åœ¨èƒ¶è´¨æ¯ç»†èƒç˜¤çš„ä¸ªæ€§åŒ–æ²»ç–—æ–¹é¢å…·æœ‰å¾ˆå¤§çš„æ½œåŠ›ã€‚

**Method**

**æ–¹æ³•**

*2.1.1. Tumor model*

*We consider the Fisherâ€“KPP PDE, a fundamental model that describes the spatio-temporal evolution of the normalized tumor celldensity ğ‘¢(ğ±, ğ‘¡) in a 3D domain ğ›º consisting of white matter (WM) andgrey matter (GM) regions (Harpold et al., 2007; Swanson et al., 2000).The PDE, with Neumann boundary conditions, is given by*

*{ğœ•ğ‘¢ğœ•ğ‘¡= ğ› â‹… (D(ğ±)ğ›ğ‘¢) ğœŒğ‘¢(1 âˆ’ ğ‘¢) in ğ›ºğ›ğ‘¢* â‹… ğ§ = 0 on ğœ•ğ›º(1)*

*where ğœŒ [1/day] is the proliferation rate and D(ğ±) [mm2/day] is thediffusion tensor, and ğ§ is the outward normal vector on the boundaryğœ•ğ›º*. We further assume that the diffusion is isotropic, and is a weightedsum of the diffusion coefficient in WM and GM, D(ğ±) = ğ·ğ‘¤ğ‘ƒw(ğ±) +ğ·ğ‘”ğ‘ƒg (ğ±), where ğ‘ƒw, ğ‘ƒg are the percentages of white and grey matter,and ğ·ğ‘¤, ğ·ğ‘” [mm2/day] are the diffusion coefficient in white and greymatter. We model heterogeneous diffusion by assuming ğ·ğ‘¤ = ğ‘ğ·ğ‘”with ğ‘ = 10 (Menze et al., 2011; LipkovÃ¡ et al., 2019; Swanson et al.,2000). For a review of this assumption and a comparison with thehomogeneous diffusion case (c = 1), see Appendix A.With the previous assumptions on the diffusion tensor, the originalPDE (1) can be written asğœ•ğ‘¢ğœ•ğ‘¡= ğ·ğ› â‹… (ğ‘ƒ (ğ±)ğ›ğ‘¢) + ğœŒğ‘¢(1 âˆ’ ğ‘¢) in ğ›º (2)*

*where ğ· = ğ·ğ‘¤ is the scalar diffusion coefficient in white matter, andğ‘ƒ* (ğ±) = ğ‘ƒğ‘¤(ğ±) + ğ‘ğ‘ƒg (ğ±) defines the geometry of the brain. Here, weloosely use the term â€˜â€˜geometryâ€™â€™ to refer to both the boundary of thebrain and the tissue distribution. Mathematically, this encompasses theboundary of the PDE domain ğœ•ğ›º and the function ğ‘ƒ (ğ±), which underliesthe heterogeneousdiffusion coefficient. We use an atlas-guided approach to obtain the geometry. In particular, we register the brain atlasused in LipkovÃ¡ et al. (2019) to patient T1w scans by diffeomorphicregistration, and we call this the registered atlas geometry, which isan approximation of the patient brain geometry. While diffeomorphicregistration works well in many cases, some errors may arise near theventricles, especially when there is significant deformation of the braindue to the tumor. For a comparison of the results using affine anddiffeomorphic registration, please see Appendix B. It remains an activearea of research to design registration methods that robustly accountfor significant distortions due to tumor mass effect and post-surgicalresection (LipkovÃ¡ et al., 2019). While we used a single brain atlas here,we could have used multiple atlases and chosen the atlas for registration that most closely matched the patient scans (Subramanian et al.,2023). We assume the initial condition is ğ‘¢0 (ğ±) = 0.1 exp( âˆ’0.1|ğ± âˆ’ ğ±0 | 2 ) ,where ğ±0 denotes the initial location of the tumor.*

æˆ‘ä»¬è€ƒè™‘è´¹å¸Œå°”-æŸ¯å°”è«å“¥æ´›å¤«-å½¼å¾—ç½—å¤«æ–¯åŸº-çš®æ–¯åº“è¯ºå¤«ï¼ˆFisherâ€“KPPï¼‰åå¾®åˆ†æ–¹ç¨‹ï¼Œè¿™æ˜¯ä¸€ä¸ªåŸºç¡€æ¨¡å‹ï¼Œç”¨äºæè¿°åœ¨ç”±ç™½è´¨ï¼ˆWMï¼‰å’Œç°è´¨ï¼ˆGMï¼‰åŒºåŸŸç»„æˆçš„ä¸‰ç»´åŒºåŸŸ(\Omega)ä¸­ï¼Œå½’ä¸€åŒ–è‚¿ç˜¤ç»†èƒå¯†åº¦(u(\mathbf{x}, t))çš„æ—¶ç©ºæ¼”åŒ–è¿‡ç¨‹ï¼ˆå“ˆæ³¢å°”å¾·ç­‰äººï¼Œ2007å¹´ï¼›æ–¯æ—ºæ£®ç­‰äººï¼Œ2000å¹´ï¼‰ã€‚è¯¥åå¾®åˆ†æ–¹ç¨‹å¸¦æœ‰è¯ºä¼Šæ›¼è¾¹ç•Œæ¡ä»¶ï¼Œè¡¨è¾¾å¼å¦‚ä¸‹ï¼š (\begin{cases} \frac{\partial u}{\partial t} = \nabla \cdot (D(\mathbf{x})\nabla u) + \rho u(1 - u) &\text{åœ¨ }\Omega\text{ å†…}\ \nabla u \cdot \mathbf{n} = 0 &\text{åœ¨ }\partial\Omega\text{ ä¸Š} \end{cases}) Â ï¼ˆ1ï¼‰ å…¶ä¸­ï¼Œ(\rho) [1/å¤©] æ˜¯å¢æ®–é€Ÿç‡ï¼Œ(D(\mathbf{x})) [(mm^2)/å¤©] æ˜¯æ‰©æ•£å¼ é‡ï¼Œ(\mathbf{n}) æ˜¯è¾¹ç•Œ(\partial\Omega)ä¸Šçš„å‘å¤–æ³•å‘é‡ã€‚æˆ‘ä»¬è¿›ä¸€æ­¥å‡è®¾æ‰©æ•£æ˜¯å„å‘åŒæ€§çš„ï¼Œå¹¶ä¸”æ˜¯ç™½è´¨å’Œç°è´¨ä¸­æ‰©æ•£ç³»æ•°çš„åŠ æƒå’Œï¼Œå³(D(\mathbf{x}) = D_w P_w(\mathbf{x}) + D_g P_g(\mathbf{x}))ï¼Œå…¶ä¸­(P_w)ã€(P_g) åˆ†åˆ«æ˜¯ç™½è´¨å’Œç°è´¨çš„ç™¾åˆ†æ¯”ï¼Œ(D_w)ã€(D_g) [(mm^2)/å¤©] æ˜¯ç™½è´¨å’Œç°è´¨ä¸­çš„æ‰©æ•£ç³»æ•°ã€‚æˆ‘ä»¬é€šè¿‡å‡è®¾(D_w = cD_g)ï¼ˆå…¶ä¸­(c = 10)ï¼‰æ¥å¯¹éå‡åŒ€æ‰©æ•£è¿›è¡Œå»ºæ¨¡ï¼ˆé—¨æ³½ç­‰äººï¼Œ2011å¹´ï¼›åˆ©æ™®ç§‘å¨ƒç­‰äººï¼Œ2019å¹´ï¼›æ–¯æ—ºæ£®ç­‰äººï¼Œ2000å¹´ï¼‰ã€‚å…³äºè¿™ä¸€å‡è®¾çš„å›é¡¾ä»¥åŠä¸å‡åŒ€æ‰©æ•£æƒ…å†µï¼ˆ(c = 1)ï¼‰çš„æ¯”è¾ƒï¼Œè§é™„å½•Aã€‚ åŸºäºå…ˆå‰å¯¹æ‰©æ•£å¼ é‡çš„å‡è®¾ï¼ŒåŸå§‹åå¾®åˆ†æ–¹ç¨‹ï¼ˆ1ï¼‰å¯ä»¥å†™æˆï¼š (\frac{\partial u}{\partial t} = D\nabla \cdot (P(\mathbf{x})\nabla u) + \rho u(1 - u)) åœ¨(\Omega)å†… Â ï¼ˆ2ï¼‰ å…¶ä¸­ï¼Œ(D = D_w) æ˜¯ç™½è´¨ä¸­çš„æ ‡é‡æ‰©æ•£ç³»æ•°ï¼Œ(P(\mathbf{x}) = P_w(\mathbf{x}) + cP_g(\mathbf{x})) å®šä¹‰äº†å¤§è„‘çš„å‡ ä½•ç»“æ„ã€‚è¿™é‡Œï¼Œæˆ‘ä»¬å®½æ³›åœ°ä½¿ç”¨â€œå‡ ä½•ç»“æ„â€è¿™ä¸ªæœ¯è¯­æ¥æŒ‡ä»£å¤§è„‘çš„è¾¹ç•Œä»¥åŠç»„ç»‡åˆ†å¸ƒã€‚ä»æ•°å­¦è§’åº¦æ¥çœ‹ï¼Œè¿™åŒ…æ‹¬åå¾®åˆ†æ–¹ç¨‹åŒºåŸŸçš„è¾¹ç•Œ(\partial\Omega) ä»¥åŠå‡½æ•°(P(\mathbf{x}))ï¼Œå®ƒæ˜¯ä¸å‡åŒ€æ‰©æ•£ç³»æ•°çš„åŸºç¡€ã€‚æˆ‘ä»¬é‡‡ç”¨å›¾è°±å¼•å¯¼çš„æ–¹æ³•æ¥è·å–å‡ ä½•ç»“æ„ã€‚å…·ä½“è€Œè¨€ï¼Œæˆ‘ä»¬é€šè¿‡å¾®åˆ†åŒèƒšé…å‡†ï¼Œå°†åˆ©æ™®ç§‘å¨ƒç­‰äººï¼ˆ2019å¹´ï¼‰ä¸­ä½¿ç”¨çš„å¤§è„‘å›¾è°±é…å‡†åˆ°æ‚£è€…çš„T1åŠ æƒï¼ˆT1wï¼‰æ‰«æå›¾åƒä¸Šï¼Œæˆ‘ä»¬å°†æ­¤ç§°ä¸ºé…å‡†åçš„å›¾è°±å‡ ä½•ç»“æ„ï¼Œå®ƒæ˜¯å¯¹æ‚£è€…å¤§è„‘å‡ ä½•ç»“æ„çš„ä¸€ç§è¿‘ä¼¼ã€‚è™½ç„¶å¾®åˆ†åŒèƒšé…å‡†åœ¨å¾ˆå¤šæƒ…å†µä¸‹æ•ˆæœè‰¯å¥½ï¼Œä½†åœ¨è„‘å®¤é™„è¿‘å¯èƒ½ä¼šå‡ºç°ä¸€äº›è¯¯å·®ï¼Œå°¤å…¶æ˜¯å½“å¤§è„‘ç”±äºè‚¿ç˜¤è€Œå‘ç”Ÿæ˜¾è‘—å˜å½¢æ—¶ã€‚å…³äºä½¿ç”¨ä»¿å°„é…å‡†å’Œå¾®åˆ†åŒèƒšé…å‡†çš„ç»“æœæ¯”è¾ƒï¼Œè¯·è§é™„å½•Bã€‚è®¾è®¡èƒ½å¤Ÿç¨³å¥åœ°è€ƒè™‘ç”±äºè‚¿ç˜¤è´¨é‡æ•ˆåº”å’Œæœ¯ååˆ‡é™¤å¯¼è‡´çš„æ˜¾è‘—å˜å½¢çš„é…å‡†æ–¹æ³•ï¼Œä»ç„¶æ˜¯ä¸€ä¸ªæ´»è·ƒçš„ç ”ç©¶é¢†åŸŸï¼ˆåˆ©æ™®ç§‘å¨ƒç­‰äººï¼Œ2019å¹´ï¼‰ã€‚è™½ç„¶æˆ‘ä»¬è¿™é‡Œä½¿ç”¨äº†å•ä¸ªå¤§è„‘å›¾è°±ï¼Œä½†æˆ‘ä»¬æœ¬å¯ä»¥ä½¿ç”¨å¤šä¸ªå›¾è°±ï¼Œå¹¶é€‰æ‹©ä¸æ‚£è€…æ‰«æå›¾åƒæœ€åŒ¹é…çš„å›¾è°±è¿›è¡Œé…å‡†ï¼ˆè‹å¸ƒæ‹‰é©¬å°¼äºšå§†ç­‰äººï¼Œ2023å¹´ï¼‰ã€‚æˆ‘ä»¬å‡è®¾åˆå§‹æ¡ä»¶ä¸º(u_0(\mathbf{x}) = 0.1 \exp( -0.1|\mathbf{x} - \mathbf{x}0|^2 ))ï¼Œå…¶ä¸­(\mathbf{x}0) è¡¨ç¤ºè‚¿ç˜¤çš„åˆå§‹ä½ç½®ã€‚

**Conclusion**

**ç»“è®º**

*We presented a method employing Physics-Informed Neural Networks (PINNs) to estimate patient-specific parameters of a reactionâ€“diffusion PDE model for the growth of GBM tumors from a singlesnapshot of structural MRI scans. We applied a simple procedure toestimate patient-specific characteristic parameters of the PDE modelusing a 1D model in spherically symmetric geometries and a grid-searchprocedure. The characteristic parameters allowed us to scale the PDE tolearn parameters that are close to unity, and helped us to pre-train thePINN to learn a characteristic solution before fine-tuning the networkwith patient data to estimate the patient-specific parameters, leadingto a more efficient method. Verified on synthetic and patient datasets,the results presented here provide a proof-of-concept that PINNs holdgreat promise for combining medical images and biophysical modelsfor patient-specific tumor growth prediction and treatment planning.*

æˆ‘ä»¬æå‡ºäº†ä¸€ç§åˆ©ç”¨åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œï¼ˆPINNsï¼‰ï¼Œä»ä¸€å¼ ç»“æ„ç£å…±æŒ¯æˆåƒï¼ˆMRIï¼‰æ‰«æçš„å•å¼ å¿«ç…§ä¸­ï¼Œä¼°è®¡èƒ¶è´¨æ¯ç»†èƒç˜¤ï¼ˆGBMï¼‰ç”Ÿé•¿çš„ååº”-æ‰©æ•£åå¾®åˆ†æ–¹ç¨‹ï¼ˆPDEï¼‰æ¨¡å‹ä¸­ç‰¹å®šæ‚£è€…å‚æ•°çš„æ–¹æ³•ã€‚ æˆ‘ä»¬é‡‡ç”¨äº†ä¸€ä¸ªç®€å•çš„ç¨‹åºï¼Œé€šè¿‡åœ¨çƒå¯¹ç§°å‡ ä½•ç»“æ„ä¸­ä½¿ç”¨ä¸€ç»´æ¨¡å‹å’Œç½‘æ ¼æœç´¢ç¨‹åºï¼Œæ¥ä¼°è®¡åå¾®åˆ†æ–¹ç¨‹æ¨¡å‹ä¸­ç‰¹å®šæ‚£è€…çš„ç‰¹å¾å‚æ•°ã€‚è¿™äº›ç‰¹å¾å‚æ•°ä½¿æˆ‘ä»¬èƒ½å¤Ÿå¯¹åå¾®åˆ†æ–¹ç¨‹è¿›è¡Œç¼©æ”¾ï¼Œä»è€Œå­¦ä¹ æ¥è¿‘å•ä½å€¼çš„å‚æ•°ã€‚å¹¶ä¸”ï¼Œå®ƒä»¬å¸®åŠ©æˆ‘ä»¬åœ¨ä½¿ç”¨æ‚£è€…æ•°æ®å¯¹ç½‘ç»œè¿›è¡Œå¾®è°ƒä»¥ä¼°è®¡ç‰¹å®šæ‚£è€…å‚æ•°ä¹‹å‰ï¼Œå¯¹åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œè¿›è¡Œé¢„è®­ç»ƒï¼Œä½¿å…¶å­¦ä¹ ä¸€ä¸ªç‰¹å¾è§£ï¼Œè¿›è€Œäº§ç”Ÿäº†ä¸€ç§æ›´é«˜æ•ˆçš„æ–¹æ³•ã€‚ é€šè¿‡åœ¨åˆæˆæ•°æ®é›†å’Œæ‚£è€…æ•°æ®é›†ä¸Šè¿›è¡ŒéªŒè¯ï¼Œæœ¬æ–‡å‘ˆç°çš„ç»“æœæä¾›äº†ä¸€ä¸ªæ¦‚å¿µéªŒè¯ï¼Œå³åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œåœ¨ç»“åˆåŒ»å­¦å›¾åƒå’Œç”Ÿç‰©ç‰©ç†æ¨¡å‹ï¼Œä»¥è¿›è¡Œç‰¹å®šæ‚£è€…çš„è‚¿ç˜¤ç”Ÿé•¿é¢„æµ‹å’Œæ²»ç–—è§„åˆ’æ–¹é¢ï¼Œå…·æœ‰å·¨å¤§çš„æ½œåŠ›ã€‚

**Results**

**ç»“æœ**

*We start by presenting an overview of the results and our findings.In this work we use 3 different datasets, including data from 24patients, to test and validate our approach:*

*â€¢ Synthetically-generated data, denoted as S1â€“S8: We specify theground truth (GT) parameters, solve the PDE by the FDM to obtain the cell density, add spatially correlated noise to the density,and generate synthetic segmentations and FET distributions.*

*â€¢ Data from 8 patients (P1â€“P8), primary tumors and first detectedrecurrence, from LipkovÃ¡ et al. (2019). All the patients have TCand WT segmentations at recurrence.*

*â€¢ Data from 16 patients (Q1â€“Q16), primary and first detected recurrence, from the Klinikum Rechts Der Isar repository. At recurrence, patients Q1â€“Q3 have both TC and WT segmentations, theothers only have TC segmentation.*

*We test parameter estimation using segmentations data and FETPET (denoted as FET+SEG), and using segmentations alone (denoted as*SEG). The difference between the two lies in the loss functions used inthe fine-tuning stage: FET+SEG includes the FET loss îˆ¸FET, in additionto the segmentation loss îˆ¸SEG.*

*We demonstrate that using segmentation alone achieves resultscomparable to those using segmentation and FET, in contrast to theresults in LipkovÃ¡ et al. (2019) where FET was needed to more accurately determine spatial distributions of the cells, particularly near thetumor center. This finding is noteworthy as FET-PET data is not widelyavailable from the clinic, thereby accentuating the practicality of ourapproach.Furthermore, we examine two methods to predict cell density afterfine-tuning: ğ‘¢ ğ¹ğ·ğ‘€ , derived from solving the PDE with estimated parameters using the FDM, and ğ‘¢ ğ‘ƒ ğ¼ğ‘ğ‘ , obtained by evaluating the PINN.We show that ğ‘¢ ğ¹ğ·ğ‘€ is more accurate in solving the PDE as ğ‘¢ ğ‘ƒ ğ¼ğ‘ğ‘ isinfluenced by the noisy data via the loss function. Additionally, theFDM can be used to solve the PDE to any non-dimensional time. However, extending the PDE solution to future times with the PINN requiresre-sampling and extending the collocation points, and retraining thenetwork with the PDE loss, which tends to be more time consuming.*

æˆ‘ä»¬é¦–å…ˆå¯¹ç ”ç©¶ç»“æœå’Œå‘ç°è¿›è¡Œæ¦‚è¿°ã€‚ åœ¨è¿™é¡¹å·¥ä½œä¸­ï¼Œæˆ‘ä»¬ä½¿ç”¨äº†3ç§ä¸åŒçš„æ•°æ®é›†ï¼Œå…¶ä¸­åŒ…å«æ¥è‡ª24åæ‚£è€…çš„æ•°æ®ï¼Œä»¥æ­¤æ¥æµ‹è¯•å’ŒéªŒè¯æˆ‘ä»¬çš„æ–¹æ³•ï¼š

åˆæˆç”Ÿæˆçš„æ•°æ®ï¼Œæ ‡è®°ä¸ºS1-S8ï¼šæˆ‘ä»¬æŒ‡å®šçœŸå®å€¼ï¼ˆGTï¼‰å‚æ•°ï¼Œé€šè¿‡æœ‰é™å·®åˆ†æ³•ï¼ˆFDMï¼‰æ±‚è§£åå¾®åˆ†æ–¹ç¨‹ä»¥è·å¾—ç»†èƒå¯†åº¦ï¼Œå‘è¯¥å¯†åº¦æ·»åŠ ç©ºé—´ç›¸å…³å™ªå£°ï¼Œå¹¶ç”Ÿæˆåˆæˆçš„åˆ†å‰²ç»“æœå’Œæ°Ÿä¹™åŸºé…ªæ°¨é…¸ï¼ˆFETï¼‰åˆ†å¸ƒã€‚

æ¥è‡ªLipkovÃ¡ç­‰äººï¼ˆ2019å¹´ï¼‰ç ”ç©¶ä¸­8åæ‚£è€…ï¼ˆP1-P8ï¼‰çš„åŸå‘æ€§è‚¿ç˜¤å’Œé¦–æ¬¡æ£€æµ‹åˆ°çš„å¤å‘è‚¿ç˜¤æ•°æ®ã€‚æ‰€æœ‰æ‚£è€…åœ¨è‚¿ç˜¤å¤å‘æ—¶éƒ½æœ‰è‚¿ç˜¤æ ¸å¿ƒï¼ˆTCï¼‰å’Œå…¨è‚¿ç˜¤ï¼ˆWTï¼‰çš„åˆ†å‰²æ•°æ®ã€‚æ¥è‡ªæ…•å°¼é»‘å¤§å­¦ä¼Šè¨å°”å³å²¸åŒ»é™¢ï¼ˆKlinikum Rechts Der Isarï¼‰æ•°æ®åº“ä¸­16åæ‚£è€…ï¼ˆQ1-Q16ï¼‰çš„åŸå‘æ€§è‚¿ç˜¤å’Œé¦–æ¬¡æ£€æµ‹åˆ°çš„å¤å‘è‚¿ç˜¤æ•°æ®ã€‚åœ¨è‚¿ç˜¤å¤å‘æ—¶ï¼Œæ‚£è€…Q1-Q3æ—¢æœ‰è‚¿ç˜¤æ ¸å¿ƒï¼ˆTCï¼‰åˆæœ‰å…¨è‚¿ç˜¤ï¼ˆWTï¼‰çš„åˆ†å‰²æ•°æ®ï¼Œå…¶ä»–æ‚£è€…ä»…æœ‰è‚¿ç˜¤æ ¸å¿ƒï¼ˆTCï¼‰çš„åˆ†å‰²æ•°æ®ã€‚ æˆ‘ä»¬ä½¿ç”¨åˆ†å‰²æ•°æ®å’Œæ°Ÿä¹™åŸºé…ªæ°¨é…¸æ­£ç”µå­å‘å°„æ–­å±‚æ‰«æï¼ˆFET-PETï¼‰æ•°æ®ï¼ˆæ ‡è®°ä¸ºFET+SEGï¼‰ï¼Œä»¥åŠä»…ä½¿ç”¨åˆ†å‰²æ•°æ®ï¼ˆæ ‡è®°ä¸ºSEGï¼‰æ¥æµ‹è¯•å‚æ•°ä¼°è®¡ã€‚è¿™ä¸¤ç§æ–¹å¼çš„åŒºåˆ«åœ¨äºå¾®è°ƒé˜¶æ®µæ‰€ä½¿ç”¨çš„æŸå¤±å‡½æ•°ï¼šFET+SEGé™¤äº†åˆ†å‰²æŸå¤±å‡½æ•°(\mathcal{L}{SEG})ä¹‹å¤–ï¼Œè¿˜åŒ…å«äº†FETæŸå¤±å‡½æ•°(\mathcal{L}{FET}) ã€‚ æˆ‘ä»¬è¯æ˜äº†ï¼Œä»…ä½¿ç”¨åˆ†å‰²æ•°æ®æ‰€å–å¾—çš„ç»“æœä¸ä½¿ç”¨åˆ†å‰²æ•°æ®å’ŒFETæ•°æ®æ‰€å–å¾—çš„ç»“æœç›¸å½“ã€‚è¿™ä¸LipkovÃ¡ç­‰äººï¼ˆ2019å¹´ï¼‰çš„ç ”ç©¶ç»“æœå½¢æˆå¯¹æ¯”ï¼Œåœ¨ä»–ä»¬çš„ç ”ç©¶ä¸­ï¼Œéœ€è¦FETæ•°æ®æ¥æ›´å‡†ç¡®åœ°ç¡®å®šç»†èƒçš„ç©ºé—´åˆ†å¸ƒï¼Œå°¤å…¶æ˜¯åœ¨è‚¿ç˜¤ä¸­å¿ƒé™„è¿‘ã€‚è¿™ä¸€å‘ç°å€¼å¾—å…³æ³¨ï¼Œå› ä¸ºFET-PETæ•°æ®åœ¨ä¸´åºŠä¸Šå¹¶ä¸å¹¿æ³›å¯å¾—ï¼Œå› æ­¤å‡¸æ˜¾äº†æˆ‘ä»¬æ–¹æ³•çš„å®ç”¨æ€§ã€‚ æ­¤å¤–ï¼Œæˆ‘ä»¬ç ”ç©¶äº†ä¸¤ç§åœ¨å¾®è°ƒåé¢„æµ‹ç»†èƒå¯†åº¦çš„æ–¹æ³•ï¼š(u{FDM})ï¼Œé€šè¿‡ä½¿ç”¨æœ‰é™å·®åˆ†æ³•ç»“åˆä¼°è®¡å‚æ•°æ¥æ±‚è§£åå¾®åˆ†æ–¹ç¨‹å¾—åˆ°ï¼›ä»¥åŠ(u{PINN})ï¼Œé€šè¿‡è¯„ä¼°åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œï¼ˆPINNï¼‰å¾—åˆ°ã€‚æˆ‘ä»¬è¡¨æ˜ï¼Œ(u{FDM})åœ¨æ±‚è§£åå¾®åˆ†æ–¹ç¨‹æ–¹é¢æ›´ä¸ºå‡†ç¡®ï¼Œå› ä¸º(u{PINN})ä¼šå—åˆ°æŸå¤±å‡½æ•°ä¸­å™ªå£°æ•°æ®çš„å½±å“ã€‚æ­¤å¤–ï¼Œæœ‰é™å·®åˆ†æ³•å¯ä»¥ç”¨äºæ±‚è§£åå¾®åˆ†æ–¹ç¨‹è‡³ä»»æ„æ— é‡çº²æ—¶é—´ã€‚ç„¶è€Œï¼Œä½¿ç”¨åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œï¼ˆPINNï¼‰å°†åå¾®åˆ†æ–¹ç¨‹çš„è§£æ‰©å±•åˆ°æœªæ¥çš„æ—¶é—´ç‚¹ï¼Œéœ€è¦å¯¹é…ç½®ç‚¹è¿›è¡Œé‡æ–°é‡‡æ ·å’Œæ‰©å±•ï¼Œå¹¶ä½¿ç”¨åå¾®åˆ†æ–¹ç¨‹æŸå¤±å‡½æ•°é‡æ–°è®­ç»ƒç½‘ç»œï¼Œè¿™å¾€å¾€ä¼šæ›´åŠ è€—æ—¶ã€‚

**Figure**

**å›¾**

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/aaf1cdb7510948b482f748c9244c1a0d.png)

*Fig. 1. Overview of the parameter estimation framework. (I) Medical Images show preoperative patient T1Gd and FLAIR scans. (II) Mathematical Model includes a PartialDifferential Equation (PDE) for the tumor cell density ğ‘¢, and an imaging model that relates medical images with ğ‘¢ by thresholding (segmentation). The unknown parameters thatneed to be estimated are tabulated. (III) Physics-informed Neural Network (PINN) is used to solve the PDE and estimate parameters from data. See Fig. 2 below for a detailedworkflow. (IV) Prediction and Validation: The estimated parameters can be used in the PDE model to predict the 3D tumor cell density (right), and can be validated via DICEscores (center). Left: The personalized clinical target volume (CTV, blue) based on model predictions is compared with Radiation Therapy Oncology Group (RTOG) CTV (green)to evaluate radiation volume and coverage of tumor recurrence (efficiency).*

å›¾1ï¼šå‚æ•°ä¼°è®¡æ¡†æ¶æ¦‚è¿°ã€‚ï¼ˆIï¼‰åŒ»å­¦å›¾åƒå±•ç¤ºäº†æ‚£è€…æœ¯å‰çš„T1é’†å¢å¼ºï¼ˆT1Gdï¼‰å’Œæ¶²ä½“è¡°å‡åè½¬æ¢å¤ï¼ˆFLAIRï¼‰æ‰«æå›¾åƒã€‚ï¼ˆIIï¼‰æ•°å­¦æ¨¡å‹åŒ…æ‹¬ä¸€ä¸ªé’ˆå¯¹è‚¿ç˜¤ç»†èƒå¯†åº¦(u)çš„åå¾®åˆ†æ–¹ç¨‹ï¼ˆPDEï¼‰ï¼Œä»¥åŠä¸€ä¸ªé€šè¿‡é˜ˆå€¼å¤„ç†ï¼ˆåˆ†å‰²ï¼‰å°†åŒ»å­¦å›¾åƒä¸(u)ç›¸å…³è”çš„æˆåƒæ¨¡å‹ã€‚éœ€è¦ä¼°è®¡çš„æœªçŸ¥å‚æ•°å·²åˆ—æˆè¡¨æ ¼ã€‚ï¼ˆIIIï¼‰åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œï¼ˆPINNï¼‰ç”¨äºæ±‚è§£åå¾®åˆ†æ–¹ç¨‹ï¼Œå¹¶ä»æ•°æ®ä¸­ä¼°è®¡å‚æ•°ã€‚å…·ä½“å·¥ä½œæµç¨‹è¯¦è§ä¸‹é¢çš„å›¾2ã€‚ï¼ˆIVï¼‰é¢„æµ‹ä¸éªŒè¯ï¼šä¼°è®¡å‡ºçš„å‚æ•°å¯ç”¨äºåå¾®åˆ†æ–¹ç¨‹æ¨¡å‹ä¸­ï¼Œä»¥é¢„æµ‹ä¸‰ç»´è‚¿ç˜¤ç»†èƒå¯†åº¦ï¼ˆå³ä¾§ï¼‰ï¼Œå¹¶å¯é€šè¿‡DICEç³»æ•°è¿›è¡ŒéªŒè¯ï¼ˆä¸­é—´ï¼‰ã€‚å·¦ä¾§ï¼šå°†åŸºäºæ¨¡å‹é¢„æµ‹çš„ä¸ªæ€§åŒ–ä¸´åºŠé¶åŒºï¼ˆCTVï¼Œè“è‰²ï¼‰ä¸æ”¾å°„æ²»ç–—è‚¿ç˜¤åä½œç»„ï¼ˆRTOGï¼‰çš„ä¸´åºŠé¶åŒºï¼ˆCTVï¼Œç»¿è‰²ï¼‰è¿›è¡Œæ¯”è¾ƒï¼Œä»¥è¯„ä¼°æ”¾ç–—ä½“ç§¯ä»¥åŠå¯¹è‚¿ç˜¤å¤å‘çš„è¦†ç›–æƒ…å†µï¼ˆæœ‰æ•ˆæ€§ï¼‰ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/4069636f92774dc0e6d0978215e34a2e.png)

*Fig. 2. Workflow for patient-specific parameter estimation via PINN. I. Preprocessing: Register the brain atlas to the T1Gd patient scan. Solve the Cahnâ€“Hilliard equation toacquire the geometry. Compute centers and radii of Tumor Core (TC) and Whole Tumor (WT) segmentations (ğ‘…TC seg and ğ‘…W seg T ). II. Grid Search: In a spherically symmetric geometry,use a grid search algorithm to identify patient-specific characteristic values of Ì„ğ·âˆ• Ì„ğœŒ and Ì„ğ¿ such that the radii derived from the PDE solution are close to ğ‘…TC seg and ğ‘…W seg T . III.*Pre-training: Solve the PDE using a Finite Difference Method (FDM) with the patient-specific characteristic parameters (and ğœ‡îˆ° = ğœ‡îˆ¾ = 1) in the registered atlas geometry toobtain a characteristic solution Ì„ğ‘¢ ğ¹ğ·ğ‘€ . Train the PINN to solve the PDE using Ì„ğ‘¢ ğ¹ğ·ğ‘€ as data. IV. Fine-Tuning: Use the segmentation data to fine-tune the PINN and learn thepatient specific parameters ğœ‡îˆ° and ğœ‡îˆ¾. These estimated parameters are used for tumor cell density predictions.*

å›¾2. é€šè¿‡åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œï¼ˆPINNï¼‰è¿›è¡Œç‰¹å®šæ‚£è€…å‚æ•°ä¼°è®¡çš„å·¥ä½œæµç¨‹ã€‚ I. é¢„å¤„ç†ï¼šå°†å¤§è„‘å›¾è°±é…å‡†åˆ°æ‚£è€…çš„T1é’†å¢å¼ºï¼ˆT1Gdï¼‰æ‰«æå›¾åƒä¸Šã€‚æ±‚è§£å¡æ© - å¸Œåˆ©äºšå¾·ï¼ˆCahnâ€“Hilliardï¼‰æ–¹ç¨‹ä»¥è·å–å‡ ä½•ç»“æ„ã€‚è®¡ç®—è‚¿ç˜¤æ ¸å¿ƒï¼ˆTCï¼‰å’Œå…¨è‚¿ç˜¤ï¼ˆWTï¼‰åˆ†å‰²çš„ä¸­å¿ƒå’ŒåŠå¾„ï¼ˆ(R{TC \text{ seg}})å’Œ(R{WT \text{ seg}})ï¼‰ã€‚ II. ç½‘æ ¼æœç´¢ï¼šåœ¨çƒå¯¹ç§°å‡ ä½•ç»“æ„ä¸­ï¼Œä½¿ç”¨ç½‘æ ¼æœç´¢ç®—æ³•æ¥è¯†åˆ«ç‰¹å®šæ‚£è€…çš„ç‰¹å¾å€¼(\bar{D}/\bar{\rho})å’Œ(\bar{L})ï¼Œä½¿å¾—ä»åå¾®åˆ†æ–¹ç¨‹è§£å¾—å‡ºçš„åŠå¾„æ¥è¿‘(R{TC \text{ seg}})å’Œ(R{WT \text{ seg}})ã€‚ III. é¢„è®­ç»ƒï¼šåœ¨é…å‡†åçš„å›¾è°±å‡ ä½•ç»“æ„ä¸­ï¼Œä½¿ç”¨æœ‰é™å·®åˆ†æ³•ï¼ˆFDMï¼‰ï¼Œç»“åˆç‰¹å®šæ‚£è€…çš„ç‰¹å¾å‚æ•°ï¼ˆä¸”(\mu{\mathcal{D}} = \mu{\mathcal{R}} = 1)ï¼‰æ¥æ±‚è§£åå¾®åˆ†æ–¹ç¨‹ï¼Œä»¥è·å¾—ç‰¹å¾è§£(\bar{u}{FDM})ã€‚ä½¿ç”¨(\bar{u}{FDM})ä½œä¸ºæ•°æ®æ¥è®­ç»ƒåŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œï¼ˆPINNï¼‰ä»¥æ±‚è§£åå¾®åˆ†æ–¹ç¨‹ã€‚ IV. å¾®è°ƒï¼šä½¿ç”¨åˆ†å‰²æ•°æ®å¯¹åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œï¼ˆPINNï¼‰è¿›è¡Œå¾®è°ƒï¼Œå¹¶å­¦ä¹ ç‰¹å®šæ‚£è€…çš„å‚æ•°(\mu{\mathcal{D}})å’Œ(\mu{\mathcal{R}})ã€‚è¿™äº›ä¼°è®¡å‡ºçš„å‚æ•°å°†ç”¨äºè‚¿ç˜¤ç»†èƒå¯†åº¦çš„é¢„æµ‹ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/81ac836f328a28f7afff81129b9b9e16.png)

*Fig. 3. Validation using synthetic data. Row 1: (a)â€“(d). ground truth (GT) data; Row2: (e)â€“(h). Training data based on GT data with spatially correlated noise; Row 3:(i)â€“(l). Parameter estimation using noisy, synthetic FET+SEG data and predictions byevaluating the PINN solution, ğ‘¢ ğ‘ƒ ğ¼ğ‘ğ‘ ; Row 4: (m)â€“(p). Parameter estimation usingnoisy FET+SEG data and predictions using the FDM solution of the PDE, ğ‘¢ ğ¹ğ·ğ‘€ , withinferred parameters; Row 5: (q)â€“(t). Parameter estimation using only the noisy SEGdata and predictions using ğ‘¢ ğ¹ğ·ğ‘€ . (t): Comparison of contours at 1%, 25%, 50%, and75% between ğ‘¢ ğ¹ğ·ğ‘€ (solid) and GT ğ‘¢ (dotted). Column 1: 3D isosurfaces of tumor celldensity at 1% and ğ‘¦ WT ; Column 2: Cell densities; Column 3: Synthetic segmentationsmimicking TC and WT data; Column 4: Synthetic FET-PET distributions. Further, (k),(o) and (s) show comparisons of predicted segmentations (linesâ€“dashed, solid) withGT segmentations (filled). Comparing rows 3 and 4, ğ‘¢ ğ‘ƒ ğ¼ğ‘ğ‘ is less accurate than ğ‘¢ ğ¹ğ·ğ‘€as a solution of the PDE with the inferred parameters because ğ‘¢ ğ‘ƒ ğ¼ğ‘ğ‘ is more stronglyinfluenced by the noisy data. Notably, the estimated cell densities from the ğ‘¢ ğ¹ğ·ğ‘€ usingFET+SEG** and SEG in rows 4 and 5, respectively, are very similar and yield accurateapproximations of the GT data*

å›¾3. ä½¿ç”¨åˆæˆæ•°æ®è¿›è¡ŒéªŒè¯ã€‚ç¬¬ä¸€è¡Œï¼š(a)è‡³(d)ä¸ºçœŸå®å€¼ï¼ˆGTï¼‰æ•°æ®ï¼›ç¬¬äºŒè¡Œï¼š(e)è‡³(h)ä¸ºåŸºäºå¸¦æœ‰ç©ºé—´ç›¸å…³å™ªå£°çš„çœŸå®å€¼æ•°æ®çš„è®­ç»ƒæ•°æ®ï¼›ç¬¬ä¸‰è¡Œï¼š(i)è‡³(l)ä¸ºä½¿ç”¨å¸¦æœ‰å™ªå£°çš„åˆæˆFET+SEGæ•°æ®è¿›è¡Œå‚æ•°ä¼°è®¡ï¼Œå¹¶é€šè¿‡è¯„ä¼°åŸºäºç‰©ç†ä¿¡æ¯çš„ç¥ç»ç½‘ç»œï¼ˆPINNï¼‰çš„è§£(u{PINN})æ¥è¿›è¡Œé¢„æµ‹ï¼›ç¬¬å››è¡Œï¼š(m)è‡³(p)ä¸ºä½¿ç”¨å¸¦æœ‰å™ªå£°çš„FET+SEGæ•°æ®è¿›è¡Œå‚æ•°ä¼°è®¡ï¼Œå¹¶ä½¿ç”¨åŸºäºæ¨æ–­å‚æ•°çš„åå¾®åˆ†æ–¹ç¨‹çš„æœ‰é™å·®åˆ†æ³•ï¼ˆFDMï¼‰è§£(u{FDM})æ¥è¿›è¡Œé¢„æµ‹ï¼›ç¬¬äº”è¡Œï¼š(q)è‡³(t)ä¸ºä»…ä½¿ç”¨å¸¦æœ‰å™ªå£°çš„SEGæ•°æ®è¿›è¡Œå‚æ•°ä¼°è®¡ï¼Œå¹¶ä½¿ç”¨(u{FDM})æ¥è¿›è¡Œé¢„æµ‹ã€‚(t)ï¼š(u{FDM})ï¼ˆå®çº¿ï¼‰ä¸çœŸå®å€¼(u)ï¼ˆè™šçº¿ï¼‰åœ¨1%ã€25%ã€50%å’Œ75%æ°´å¹³ä¸‹çš„è½®å»“æ¯”è¾ƒã€‚ç¬¬ä¸€åˆ—ï¼šè‚¿ç˜¤ç»†èƒå¯†åº¦åœ¨1%å’Œ(y{WT})æ°´å¹³ä¸‹çš„ä¸‰ç»´ç­‰å€¼é¢ï¼›ç¬¬äºŒåˆ—ï¼šç»†èƒå¯†åº¦ï¼›ç¬¬ä¸‰åˆ—ï¼šæ¨¡æ‹Ÿè‚¿ç˜¤æ ¸å¿ƒï¼ˆTCï¼‰å’Œå…¨è‚¿ç˜¤ï¼ˆWTï¼‰æ•°æ®çš„åˆæˆåˆ†å‰²ç»“æœï¼›ç¬¬å››åˆ—ï¼šåˆæˆçš„æ°Ÿä¹™åŸºé…ªæ°¨é…¸æ­£ç”µå­å‘å°„æ–­å±‚æ‰«æï¼ˆFET-PETï¼‰åˆ†å¸ƒã€‚æ­¤å¤–ï¼Œ(k)ã€(o)å’Œ(s)å±•ç¤ºäº†é¢„æµ‹çš„åˆ†å‰²ç»“æœï¼ˆè™šçº¿ã€å®çº¿ï¼‰ä¸çœŸå®å€¼åˆ†å‰²ç»“æœï¼ˆå¡«å……åŒºåŸŸï¼‰çš„æ¯”è¾ƒã€‚æ¯”è¾ƒç¬¬ä¸‰è¡Œå’Œç¬¬å››è¡Œå¯çŸ¥ï¼Œä½œä¸ºåŸºäºæ¨æ–­å‚æ•°çš„åå¾®åˆ†æ–¹ç¨‹çš„è§£ï¼Œ(u{PINN})çš„å‡†ç¡®æ€§ä¸å¦‚(u{FDM})ï¼Œå› ä¸º(u{PINN})å—å™ªå£°æ•°æ®çš„å½±å“æ›´å¤§ã€‚å€¼å¾—æ³¨æ„çš„æ˜¯ï¼Œåˆ†åˆ«åœ¨ç¬¬å››è¡Œå’Œç¬¬äº”è¡Œä¸­ï¼Œä½¿ç”¨FET+SEGå’ŒSEGæ•°æ®é€šè¿‡(u_{FDM})ä¼°è®¡çš„ç»†èƒå¯†åº¦éå¸¸ç›¸ä¼¼ï¼Œå¹¶ä¸”èƒ½å¤Ÿå‡†ç¡®åœ°é€¼è¿‘çœŸå®å€¼æ•°æ®ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/099f9f9290d22f2e1a642170f56f7b31.png)

*Fig. 4. Predicted tumor morphologies at times different from that of training data.Morphologies are shown at the normalized times ğ‘¡Ì„ = 0.6, 0.8, 1.0, 1.2 and are obtainedusing ğ‘¢ ğ¹ğ·ğ‘€ with parameters inferred from the synthetic data in Fig. 3. Only SEG data isused for inference and the training data corresponds to the normalized time ğ‘¡Ì„ = 1. Row1: 3D isosurfaces of ğ‘¢ ğ¹ğ·ğ‘€ at 1% and 30% Row 2: Comparison of predicted contours(solid; 1%, 25%, 50% and 75%) with GT (dotted)*

å›¾4. åœ¨ä¸è®­ç»ƒæ•°æ®ä¸åŒæ—¶é—´ç‚¹çš„é¢„æµ‹è‚¿ç˜¤å½¢æ€ã€‚å½¢æ€å±•ç¤ºäºå½’ä¸€åŒ–æ—¶é—´(\bar{t}=0.6)ã€(0.8)ã€(1.0)ã€(1.2)ï¼Œä¸”æ˜¯ä½¿ç”¨(u{FDM})å¾—åˆ°çš„ï¼Œå…¶ä¸­å‚æ•°æ˜¯ä»å›¾3çš„åˆæˆæ•°æ®ä¸­æ¨æ–­è€Œæ¥ã€‚ä»…ä½¿ç”¨SEGæ•°æ®è¿›è¡Œæ¨æ–­ï¼Œå¹¶ä¸”è®­ç»ƒæ•°æ®å¯¹åº”äºå½’ä¸€åŒ–æ—¶é—´(\bar{t} = 1)ã€‚ç¬¬ä¸€è¡Œï¼š(u{FDM})åœ¨1%å’Œ30%æ°´å¹³ä¸‹çš„ä¸‰ç»´ç­‰å€¼é¢ï¼›ç¬¬äºŒè¡Œï¼šé¢„æµ‹è½®å»“ï¼ˆå®çº¿ï¼›1%ã€25%ã€50%å’Œ75%æ°´å¹³ï¼‰ä¸çœŸå®å€¼ï¼ˆè™šçº¿ï¼‰çš„æ¯”è¾ƒ

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/a8668a7a017765d76c5abba62eda4b05.png)

*Fig. 5. Predicted patient-specific tumor morphologies, cell densities and FET-PETdistributions from Patient 5. Row 1: Medical images: (a) T1Gd; (b) FLAIR; (c) Postprocessed FET-PET (see Section 2.1.4); (d) Original FET-PET data. Row 2: ğ‘¢ ğ¹ğ·ğ‘€predictions using FET+SEG data. Row 3: ğ‘¢ ğ¹ğ·ğ‘€ predictions using SEG data only. (e)and (i): Predicted cell density distributions from ğ‘¢ ğ¹ğ·ğ‘€ together with boundaries of thesegmentations (curves) from the MRI images. (f) and (j): Comparisons of the contours ofğ‘¢* ğ¹ğ·ğ‘€ at the inferred segmentation thresholds (curves) with MRI segmentations (filled).Margins for CTV RTOG (green) and CTV P (blue); (g) predicted FET-PET distribution.(h) 3D visualization of 1% and ğ‘¢ W ğ‘ T isosurfaces. (k) Comparison of 1%, ğ‘¢ W ğ‘ T , and ğ‘¢ TC ğ‘contours of ğ‘¢ ğ¹ğ·ğ‘€ (solid) and ğ‘¢ ğ‘ƒ ğ¼ğ‘ğ‘ (dashed). (l) Predicted cell density distributionsfrom ğ‘¢ ğ¹ğ·ğ‘€ on the registered atlas, together with ğœ•ğ›º (orange)*

å›¾5. æ¥è‡ªæ‚£è€…5çš„ç‰¹å®šæ‚£è€…çš„é¢„æµ‹è‚¿ç˜¤å½¢æ€ã€ç»†èƒå¯†åº¦ä»¥åŠæ°Ÿä¹™åŸºé…ªæ°¨é…¸æ­£ç”µå­å‘å°„æ–­å±‚æ‰«æï¼ˆFET-PETï¼‰åˆ†å¸ƒã€‚ç¬¬ä¸€è¡Œï¼šåŒ»å­¦å›¾åƒï¼š(a) T1é’†å¢å¼ºï¼ˆT1Gdï¼‰å›¾åƒï¼›(b) æ¶²ä½“è¡°å‡åè½¬æ¢å¤ï¼ˆFLAIRï¼‰å›¾åƒï¼›(c) åå¤„ç†çš„FET-PETå›¾åƒï¼ˆè§2.1.4èŠ‚ï¼‰ï¼›(d) åŸå§‹çš„FET-PETæ•°æ®ã€‚ç¬¬äºŒè¡Œï¼šä½¿ç”¨FET+SEGæ•°æ®å¾—åˆ°çš„(u{FDM})é¢„æµ‹ç»“æœã€‚ç¬¬ä¸‰è¡Œï¼šä»…ä½¿ç”¨SEGæ•°æ®å¾—åˆ°çš„(u{FDM})é¢„æµ‹ç»“æœã€‚(e)å’Œ(i)ï¼šç”±(u{FDM})é¢„æµ‹çš„ç»†èƒå¯†åº¦åˆ†å¸ƒï¼Œä»¥åŠæ¥è‡ªMRIå›¾åƒçš„åˆ†å‰²è¾¹ç•Œï¼ˆæ›²çº¿ï¼‰ã€‚(f)å’Œ(j)ï¼šåœ¨æ¨æ–­çš„åˆ†å‰²é˜ˆå€¼ä¸‹(u{FDM})çš„è½®å»“ï¼ˆæ›²çº¿ï¼‰ä¸MRIåˆ†å‰²ç»“æœï¼ˆå¡«å……åŒºåŸŸï¼‰çš„æ¯”è¾ƒã€‚æ”¾å°„æ²»ç–—è‚¿ç˜¤åä½œç»„ï¼ˆRTOGï¼‰çš„ä¸´åºŠé¶åŒºï¼ˆCTVï¼‰è¾¹ç•Œï¼ˆç»¿è‰²ï¼‰å’Œä¸ªæ€§åŒ–CTVï¼ˆCTV Pï¼‰è¾¹ç•Œï¼ˆè“è‰²ï¼‰ï¼›(g) é¢„æµ‹çš„FET-PETåˆ†å¸ƒã€‚(h) 1%æ°´å¹³å’Œ(u{WcT})ç­‰å€¼é¢çš„ä¸‰ç»´å¯è§†åŒ–ã€‚(k) (u{FDM})ï¼ˆå®çº¿ï¼‰å’Œ(u{PINN})ï¼ˆè™šçº¿ï¼‰åœ¨1%ã€(u{WcT})å’Œ(u{TCc})è½®å»“çš„æ¯”è¾ƒã€‚(l) åœ¨é…å‡†åçš„å›¾è°±ä¸Šç”±(u{FDM})é¢„æµ‹çš„ç»†èƒå¯†åº¦åˆ†å¸ƒï¼Œä»¥åŠ(\partial\Omega)ï¼ˆæ©™è‰²ï¼‰ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/d2cf7e54da6f2f366ece698ece698e68.png)

*Fig. 6. Predicted dynamics of tumor from Patient 5 using the FDM at normalized timesğ‘¡Ì„* = 0.6, 0.8, 1.0, 1.2. The data is provided at ğ‘¡Ì„ = 1. The 3D isosurfaces of ğ‘¢ ğ¹ğ·ğ‘€ at 1%and predicted ğ‘¢ W ğ‘ T are shown.*

å›¾6. ä½¿ç”¨æœ‰é™å·®åˆ†æ³•ï¼ˆFDMï¼‰é¢„æµ‹çš„æ‚£è€…5çš„è‚¿ç˜¤åœ¨å½’ä¸€åŒ–æ—¶é—´(\bar{t}=0.6)ã€(0.8)ã€(1.0)ã€(1.2)æ—¶çš„åŠ¨æ€å˜åŒ–æƒ…å†µã€‚æ•°æ®æ˜¯åœ¨å½’ä¸€åŒ–æ—¶é—´(\bar{t} = 1)æ—¶æä¾›çš„ã€‚å›¾ä¸­å±•ç¤ºäº†(u{FDM})åœ¨1%æ°´å¹³çš„ä¸‰ç»´ç­‰å€¼é¢ä»¥åŠé¢„æµ‹çš„(u{WcT}) ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/5d1ac2aef7680d1ae0b887c9a8896745.png)

*Fig. 7. Parameter estimation results for patients P1â€“P8 using SEG. (A) Pre-operative T1Gd. (B) Pre-operative FLAIR. (C) Superposition of predicted tumor cell density ğ‘¢ ğ¹ğ·ğ‘€ onactual segmentations: WT (yellow line) and TC (red line). (D) Superposition of predicted tumor cell density ğ‘¢ ğ¹ğ·ğ‘€ on registered atlas with ğœ•ğ›º (orange line). (E) Overlap of inferredsegmentations: ğ‘¢ W ğ‘ T (yellow line) and ğ‘¢ TC ğ‘ (red line) on actual segmentations: WT (beige fill) and TC (pink fill); Margins for CTV RTOG (green) and CTV P (blue). (F) Tumor recurrence,compared with margins for CTV RTOG (green) and CTV P (blue). (G) 3D reconstructions of CTV P an*

å›¾7ï¼šä½¿ç”¨SEGæ•°æ®å¯¹æ‚£è€…P1è‡³P8è¿›è¡Œå‚æ•°ä¼°è®¡çš„ç»“æœã€‚(A) æœ¯å‰T1é’†å¢å¼ºï¼ˆT1Gdï¼‰å›¾åƒã€‚(B) æœ¯å‰æ¶²ä½“è¡°å‡åè½¬æ¢å¤ï¼ˆFLAIRï¼‰å›¾åƒã€‚(C) é¢„æµ‹çš„è‚¿ç˜¤ç»†èƒå¯†åº¦(u{FDM})ä¸å®é™…åˆ†å‰²ç»“æœçš„å åŠ ï¼šå…¨è‚¿ç˜¤ï¼ˆWTï¼Œé»„çº¿ï¼‰å’Œè‚¿ç˜¤æ ¸å¿ƒï¼ˆTCï¼Œçº¢çº¿ï¼‰ã€‚(D) é¢„æµ‹çš„è‚¿ç˜¤ç»†èƒå¯†åº¦(u{FDM})ä¸é…å‡†åçš„å›¾è°±ä»¥åŠè¾¹ç•Œ(\partial\Omega)ï¼ˆæ©™çº¿ï¼‰çš„å åŠ ã€‚(E) æ¨æ–­çš„åˆ†å‰²ç»“æœçš„é‡å æƒ…å†µï¼š(u{WcT})ï¼ˆé»„çº¿ï¼‰å’Œ(u{TCc})ï¼ˆçº¢çº¿ï¼‰ä¸å®é™…åˆ†å‰²ç»“æœï¼šå…¨è‚¿ç˜¤ï¼ˆç±³è‰²å¡«å……åŒºåŸŸï¼‰å’Œè‚¿ç˜¤æ ¸å¿ƒï¼ˆç²‰è‰²å¡«å……åŒºåŸŸï¼‰ï¼›æ”¾å°„æ²»ç–—è‚¿ç˜¤åä½œç»„ï¼ˆRTOGï¼‰çš„ä¸´åºŠé¶åŒºï¼ˆCTVï¼‰è¾¹ç•Œï¼ˆç»¿è‰²ï¼‰å’Œä¸ªæ€§åŒ–ä¸´åºŠé¶åŒºï¼ˆCTV Pï¼‰è¾¹ç•Œï¼ˆè“è‰²ï¼‰ã€‚(F) è‚¿ç˜¤å¤å‘æƒ…å†µï¼Œä¸æ”¾å°„æ²»ç–—è‚¿ç˜¤åä½œç»„ï¼ˆRTOGï¼‰çš„ä¸´åºŠé¶åŒºï¼ˆCTVï¼‰è¾¹ç•Œï¼ˆç»¿è‰²ï¼‰å’Œä¸ªæ€§åŒ–ä¸´åºŠé¶åŒºï¼ˆCTV Pï¼‰è¾¹ç•Œï¼ˆè“è‰²ï¼‰è¿›è¡Œæ¯”è¾ƒã€‚(G) ä¸ªæ€§åŒ–ä¸´åºŠé¶åŒºï¼ˆCTV Pï¼‰çš„ä¸‰ç»´é‡å»ºã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/3e49ab61bdf7b5af232cebedd123cd8d.png)

*Fig. 8. Parameter Estimation Results for Patients Q1â€“Q8 using SEG. Recurrence results for Q1â€“Q3 are shown in Appendix I Fig . I.20. Legends are the same as 7. Results usingFET+SEGare shown in Appendix I Fig. I.18.*

å›¾8ï¼šä½¿ç”¨SEGæ•°æ®å¯¹æ‚£è€…Q1è‡³Q8è¿›è¡Œå‚æ•°ä¼°è®¡çš„ç»“æœã€‚æ‚£è€…Q1è‡³Q3çš„å¤å‘ç»“æœè§é™„å½•Iä¸­çš„å›¾I.20ã€‚å›¾ä¾‹ä¸å›¾7ç›¸åŒã€‚ä½¿ç”¨FET+SEGæ•°æ®çš„ç»“æœè§é™„å½•Iä¸­çš„å›¾I.18ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/3a00dd00fcf614381030a1334c22c6f7.png)

*Fig. 9. Parameter Estimation Results for Patients Q9â€“Q16 using SEG. Legends are the same as 7. Results using FET+SEG are shown in Appendix I Fig. I.19.*

å›¾9ï¼šä½¿ç”¨SEGæ•°æ®å¯¹æ‚£è€…Q9è‡³Q16è¿›è¡Œå‚æ•°ä¼°è®¡çš„ç»“æœã€‚å›¾ä¾‹ä¸å›¾7ç›¸åŒã€‚ä½¿ç”¨FET+SEGæ•°æ®çš„ç»“æœè§é™„å½•Iä¸­çš„å›¾I.19ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/d021a6600b1a53ad7fc607c5de9adf75.png)

*Fig. A.10. Comparison of the effect of using heterogeneous (c = 10) and homogeneous(ğ‘ = 1) diffusion. Assuming homogeneous diffusion coefficient leads to sphericalcontours and larger infiltration*

å›¾A.10ï¼šä½¿ç”¨éå‡åŒ€æ‰©æ•£ï¼ˆ(c = 10)ï¼‰å’Œå‡åŒ€æ‰©æ•£ï¼ˆ(c = 1)ï¼‰çš„æ•ˆæœæ¯”è¾ƒã€‚å‡è®¾å‡åŒ€æ‰©æ•£ç³»æ•°ä¼šå¯¼è‡´å‡ºç°çƒå½¢è½®å»“ï¼Œå¹¶ä¸”ä¼šæœ‰æ›´å¤§èŒƒå›´çš„æµ¸æ¶¦æƒ…å†µã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/a582d4dda575f4bdd0d414bbe9e55037.png)

*Fig. B.11. Estimated tumor cell density for P5 using SEG on the registered atlason the patient geometry (T1Gd, left column) and the registered atlas geometry (rightcolumn) using affine registration (top row) and diffeomorphic registration (bottomrow). Diffeomorphic registration leads to better results near the ventricles.*

å›¾B.11ï¼šå¯¹äºæ‚£è€…P5ï¼Œä½¿ç”¨SEGæ•°æ®ï¼Œåˆ†åˆ«åŸºäºæ‚£è€…è‡ªèº«å‡ ä½•ç»“æ„é…å‡†åçš„å›¾è°±ï¼ˆT1é’†å¢å¼ºå›¾åƒï¼Œå·¦åˆ—ï¼‰ä»¥åŠåŸºäºé…å‡†åçš„å›¾è°±å‡ ä½•ç»“æ„ï¼Œé‡‡ç”¨ä»¿å°„é…å‡†ï¼ˆä¸Šæ’ï¼‰å’Œå¾®åˆ†åŒèƒšé…å‡†ï¼ˆä¸‹æ’ï¼‰æ‰€ä¼°è®¡çš„è‚¿ç˜¤ç»†èƒå¯†åº¦ã€‚å¾®åˆ†åŒèƒšé…å‡†åœ¨è„‘å®¤é™„è¿‘èƒ½å¾—åˆ°æ›´å¥½çš„ç»“æœã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/48c866e6a3691479a9561da1f42404f9.png)

*Fig. E.12. Example of training loss for patient P5 with FET+SEG. The left figure showsthe training loss for pre-training with residual loss and ğ‘¢ ğ¹ğ·ğ‘€ . The right figure showsthe training loss for fine-tuning with segmentation loss and PET loss. The weights arechosen such that the two loss magnitudes are similar.*

å›¾E.12ï¼šä½¿ç”¨FET+SEGæ•°æ®å¯¹æ‚£è€…P5è¿›è¡Œè®­ç»ƒæ—¶çš„æŸå¤±ç¤ºä¾‹ã€‚å·¦å›¾å±•ç¤ºäº†åˆ©ç”¨æ®‹å·®æŸå¤±å’Œ(u_{FDM})è¿›è¡Œé¢„è®­ç»ƒæ—¶çš„è®­ç»ƒæŸå¤±æƒ…å†µã€‚å³å›¾å±•ç¤ºäº†é€šè¿‡åˆ†å‰²æŸå¤±å’Œæ­£ç”µå­å‘å°„æ–­å±‚æ‰«æï¼ˆPETï¼‰æŸå¤±è¿›è¡Œå¾®è°ƒæ—¶çš„è®­ç»ƒæŸå¤±æƒ…å†µã€‚æƒé‡çš„é€‰å–ä½¿å¾—ä¸¤ç§æŸå¤±çš„é‡çº§ç›¸è¿‘ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/7204628d16b5eb156df1ce87a2e1c2dc.png)

*Fig. F.13. The distribution of collocation points for the residual loss in the radialdirection is shown as a scatter plot with Ì„ğ‘¢ ğ¹ğ·ğ‘€ and r (radii of ğ± r ) and color-coded bytime spanning from 0 to 1. The PDE solution is concentrated at the center where thereis a larger gradient at early times, and the collocation points are densely sampledat the center and at early times. Inset (a) shows a histogram of r (normalized to aprobability density function), highlighting that due to near-uniform distribution in polarcoordinates, ğ± r is denser at the center. Inset (b) shows a histogram of time (normalizedas a probability density function), indicating a denser sampling in the earlier timeperiods.*

å›¾F.13ï¼šä»¥æ•£ç‚¹å›¾çš„å½¢å¼å±•ç¤ºäº†åœ¨å¾„å‘æ–¹å‘ä¸Šç”¨äºæ®‹å·®æŸå¤±çš„é…ç½®ç‚¹çš„åˆ†å¸ƒæƒ…å†µï¼Œå…¶ä¸­æ¨ªåæ ‡ä¸º(\bar{u}{FDM})ï¼Œçºµåæ ‡ä¸º(r)ï¼ˆ(\mathbf{x}r)çš„åŠå¾„ï¼‰ï¼Œå¹¶æ ¹æ®æ—¶é—´ï¼ˆèŒƒå›´ä»0åˆ°1ï¼‰è¿›è¡Œäº†é¢œè‰²ç¼–ç ã€‚åå¾®åˆ†æ–¹ç¨‹ï¼ˆPDEï¼‰çš„è§£é›†ä¸­åœ¨ä¸­å¿ƒä½ç½®ï¼Œåœ¨æ—©æœŸé˜¶æ®µï¼Œè¯¥ä¸­å¿ƒä½ç½®çš„æ¢¯åº¦è¾ƒå¤§ï¼Œå¹¶ä¸”é…ç½®ç‚¹åœ¨ä¸­å¿ƒä½ç½®ä»¥åŠæ—©æœŸé˜¶æ®µçš„é‡‡æ ·æ›´ä¸ºå¯†é›†ã€‚æ’å›¾(a)å±•ç¤ºäº†(r)çš„ç›´æ–¹å›¾ï¼ˆå·²å½’ä¸€åŒ–ä¸ºæ¦‚ç‡å¯†åº¦å‡½æ•°ï¼‰ï¼Œçªå‡ºæ˜¾ç¤ºäº†ç”±äºåœ¨æåæ ‡ä¸­è¿‘ä¹å‡åŒ€çš„åˆ†å¸ƒï¼Œ(\mathbf{x}_r)åœ¨ä¸­å¿ƒä½ç½®æ›´ä¸ºå¯†é›†ã€‚æ’å›¾(b)å±•ç¤ºäº†æ—¶é—´çš„ç›´æ–¹å›¾ï¼ˆå·²å½’ä¸€åŒ–ä¸ºæ¦‚ç‡å¯†åº¦å‡½æ•°ï¼‰ï¼Œè¡¨æ˜åœ¨è¾ƒæ—©çš„æ—¶é—´æ®µå†…é‡‡æ ·æ›´ä¸ºå¯†é›†ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/c2ff755d964fdc6c11f93b250949524d.png)

*Fig. G.14. Illustration of spatially correlated noise, as employed in Fig. 5. Noise isproduced by sampling from a Gaussian distribution (mean 0 and standard deviation 2)at each pixel and subsequently applying a Gaussian filter of size 13*

å›¾G.14ï¼šå¦‚å›¾5ä¸­æ‰€é‡‡ç”¨çš„ç©ºé—´ç›¸å…³å™ªå£°çš„ç¤ºæ„å›¾ã€‚å™ªå£°æ˜¯é€šè¿‡åœ¨æ¯ä¸ªåƒç´ å¤„ä»é«˜æ–¯åˆ†å¸ƒï¼ˆå‡å€¼ä¸º0ï¼Œæ ‡å‡†å·®ä¸º2ï¼‰ä¸­é‡‡æ ·ï¼Œç„¶åå†åº”ç”¨ä¸€ä¸ªå¤§å°ä¸º13çš„é«˜æ–¯æ»¤æ³¢å™¨è€Œäº§ç”Ÿçš„ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/7d230be52204f64cd9bd863e0d57e8c7.png)

*Fig. I.15. Comparison of predicted tumor cell densities ğ‘¢ ğ¹ğ·ğ‘€ and ğ‘¢ ğ‘ƒ ğ¼ğ‘ğ‘ for patientP5 using SEG data, as supplement to Fig. 5. ğ‘¢ ğ‘ƒ ğ¼ğ‘ğ‘ is influenced by the noise*

å›¾I.15ï¼šä½¿ç”¨SEGæ•°æ®ï¼Œå¯¹æ‚£è€…P5é¢„æµ‹çš„è‚¿ç˜¤ç»†èƒå¯†åº¦(u{FDM})å’Œ(u{PINN})è¿›è¡Œæ¯”è¾ƒï¼Œä½œä¸ºå¯¹å›¾5çš„è¡¥å……ã€‚(u_{PINN})ä¼šå—åˆ°å™ªå£°çš„å½±å“ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/c2eea3dc689266a07beda9472a4be1af.png)

*Fig. I.16. Parameter estimation results for patients P1â€“P8 using FET+SEG. Pre-operative T1Gd and FLAIR are identical to Fig. 7. (A) FET signal. (B) Pre-processed PET bysubtracting the background average and normalized to [0,1]. (C) Superimposition of predicted tumor cell density ğ‘¢ ğ¹ğ·ğ‘€ on actual segmentations: T1Gd (yellow line) and FLAIR(red line). (D) Predicted FET signal. (E) Overlap of inferred segmentations: ğ‘¢ W ğ‘ T (yellow line) and ğ‘¢ TC ğ‘ (red line) on actual segmentations: WT (beige fill) and TC (pink fill); Marginsfor CTV RTOG (green) and CTV P (blue). (F) Tumor recurrence, compared with margins for CTV RTOG (green) and CTV P (blue). (G) 3D reconstructions of CTV P and ğ‘¢ W ğ‘ T isosurfaces.*

å›¾I.16ï¼šä½¿ç”¨FET+SEGå¯¹æ‚£è€…P1è‡³P8çš„å‚æ•°ä¼°è®¡ç»“æœã€‚æœ¯å‰çš„T1é’†å¢å¼ºï¼ˆT1Gdï¼‰å›¾åƒå’Œæ¶²ä½“è¡°å‡åè½¬æ¢å¤ï¼ˆFLAIRï¼‰å›¾åƒä¸å›¾7ç›¸åŒã€‚(A) æ°Ÿä¹™åŸºé…ªæ°¨é…¸ï¼ˆFETï¼‰ä¿¡å·ã€‚(B) ç»è¿‡é¢„å¤„ç†çš„æ­£ç”µå­å‘å°„æ–­å±‚æ‰«æï¼ˆPETï¼‰å›¾åƒï¼Œæ–¹æ³•æ˜¯å‡å»èƒŒæ™¯å¹³å‡å€¼å¹¶å½’ä¸€åŒ–åˆ°[0,1]åŒºé—´ã€‚(C) å°†é¢„æµ‹çš„è‚¿ç˜¤ç»†èƒå¯†åº¦(u{FDM})å åŠ åœ¨å®é™…çš„åˆ†å‰²å›¾åƒä¸Šï¼šT1é’†å¢å¼ºå›¾åƒï¼ˆé»„çº¿ï¼‰å’Œæ¶²ä½“è¡°å‡åè½¬æ¢å¤å›¾åƒï¼ˆçº¢çº¿ï¼‰ã€‚(D) é¢„æµ‹çš„æ°Ÿä¹™åŸºé…ªæ°¨é…¸ï¼ˆFETï¼‰ä¿¡å·ã€‚(E) æ¨æ–­å‡ºçš„åˆ†å‰²åŒºåŸŸçš„é‡å æƒ…å†µï¼šå…¨è‚¿ç˜¤åˆ†å‰²é˜ˆå€¼å¯¹åº”çš„(u{WcT})ï¼ˆé»„çº¿ï¼‰å’Œè‚¿ç˜¤æ ¸å¿ƒåˆ†å‰²é˜ˆå€¼å¯¹åº”çš„(u{TCc})ï¼ˆçº¢çº¿ï¼‰å åŠ åœ¨å®é™…çš„åˆ†å‰²åŒºåŸŸä¸Šï¼Œå…¨è‚¿ç˜¤ï¼ˆæµ…è¤è‰²å¡«å……ï¼‰å’Œè‚¿ç˜¤æ ¸å¿ƒï¼ˆç²‰çº¢è‰²å¡«å……ï¼‰ï¼›æ”¾ç–—è‚¿ç˜¤å­¦ç»„è§„å®šçš„ä¸´åºŠé¶åŒºï¼ˆCTV({RTOG})ï¼Œç»¿è‰²ï¼‰å’Œç‰¹å®šä¸´åºŠé¶åŒºï¼ˆCTV(P)ï¼Œè“è‰²ï¼‰çš„è¾¹ç•Œã€‚(F) è‚¿ç˜¤å¤å‘æƒ…å†µï¼Œä¸æ”¾ç–—è‚¿ç˜¤å­¦ç»„è§„å®šçš„ä¸´åºŠé¶åŒºï¼ˆCTV({RTOG})ï¼Œç»¿è‰²ï¼‰å’Œç‰¹å®šä¸´åºŠé¶åŒºï¼ˆCTV(P)ï¼Œè“è‰²ï¼‰çš„è¾¹ç•Œè¿›è¡Œæ¯”è¾ƒã€‚(G) ç‰¹å®šä¸´åºŠé¶åŒºï¼ˆCTV(P)ï¼‰å’Œå…¨è‚¿ç˜¤åˆ†å‰²é˜ˆå€¼å¯¹åº”çš„(u_{WcT})ç­‰å€¼é¢çš„ä¸‰ç»´é‡å»ºå›¾ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/a3e0ac7f8fabb9f6c6d7b4ee5c0d71af.png)

*Fig. I.17. Results for patients P1â€“P8 using characteristic parameters without fine-tuning. For all cases, ğœ‡îˆ° = ğœ‡îˆ¾ = 1, ğ‘š = 1, ğ´ = 0, ğ‘¢ TC ğ‘ = 0.6, ğ‘¢ W ğ‘ T = 0.35. (a) Pre-operative T1Gd.*
*(b) Pre-operative FLAIR. (c) Superimposition of predicted tumor cell density ğ‘¢ ğ¹ğ·ğ‘€ on actual segmentations: WT (yellow line) and TC (red line). (d) Predicted FET signal. (d)*
*Overlap of inferred segmentations: ğ‘¢ W ğ‘ T (yellow line) and ğ‘¢ TC ğ‘ (red line) on actual segmentations: WT (beige fill) and TC (pink fill); Margins for CTV RTOG (green) and CTV P (glue,*

*1% contour of ğ‘¢ ğ¹ğ·ğ‘€ ). (e) Tumor recurrence, compared with margins for CTV RTOG (green) and CTV P (blue). (f) 3D reconstructions of CTV P and ğ‘¢ W ğ‘ T isosurfaces*

å›¾I.17ï¼šä½¿ç”¨æœªç»å¾®è°ƒçš„ç‰¹å¾å‚æ•°å¯¹æ‚£è€…P1è‡³P8çš„ç ”ç©¶ç»“æœã€‚åœ¨æ‰€æœ‰ç—…ä¾‹ä¸­ï¼Œ(\mu{\mathcal{D}} = \mu{\mathcal{R}} = 1)ï¼Œ(m = 1)ï¼Œ(A = 0)ï¼Œ(u{TCc}= 0.6)ï¼Œ(u{WcT}= 0.35)ã€‚(a) æœ¯å‰çš„T1é’†å¢å¼ºï¼ˆT1Gdï¼‰å›¾åƒã€‚(b) æœ¯å‰çš„æ¶²ä½“è¡°å‡åè½¬æ¢å¤ï¼ˆFLAIRï¼‰å›¾åƒã€‚(c) å°†é¢„æµ‹çš„è‚¿ç˜¤ç»†èƒå¯†åº¦(u{FDM})å åŠ åœ¨å®é™…çš„åˆ†å‰²å›¾åƒä¸Šï¼šå…¨è‚¿ç˜¤ï¼ˆWTï¼Œé»„çº¿ï¼‰å’Œè‚¿ç˜¤æ ¸å¿ƒï¼ˆTCï¼Œçº¢çº¿ï¼‰ã€‚(d) é¢„æµ‹çš„æ°Ÿä¹™åŸºé…ªæ°¨é…¸ï¼ˆFETï¼‰ä¿¡å·ã€‚ï¼ˆè¿™é‡Œä½ å†™äº†ä¸¤ä¸ª(d)ï¼Œåº”è¯¥æ˜¯æœ‰è¯¯ï¼Œå‡è®¾ç¬¬äºŒä¸ªä¸º(e)ï¼‰æ¨æ–­å‡ºçš„åˆ†å‰²åŒºåŸŸçš„é‡å æƒ…å†µï¼šå…¨è‚¿ç˜¤åˆ†å‰²é˜ˆå€¼å¯¹åº”çš„(u{WcT})ï¼ˆé»„çº¿ï¼‰å’Œè‚¿ç˜¤æ ¸å¿ƒåˆ†å‰²é˜ˆå€¼å¯¹åº”çš„(u{TCc})ï¼ˆçº¢çº¿ï¼‰å åŠ åœ¨å®é™…çš„åˆ†å‰²åŒºåŸŸä¸Šï¼Œå…¨è‚¿ç˜¤ï¼ˆæµ…è¤è‰²å¡«å……ï¼‰å’Œè‚¿ç˜¤æ ¸å¿ƒï¼ˆç²‰çº¢è‰²å¡«å……ï¼‰ï¼›æ”¾ç–—è‚¿ç˜¤å­¦ç»„è§„å®šçš„ä¸´åºŠé¶åŒºï¼ˆCTV({RTOG})ï¼Œç»¿è‰²ï¼‰å’Œç‰¹å®šä¸´åºŠé¶åŒºï¼ˆCTV(P)ï¼Œæ­¤å¤„åŸæ–‡æœ¬â€œglueâ€åº”ä¸ºâ€œblueâ€ï¼Œè“è‰²ï¼Œæ˜¯(u{FDM})çš„1%ç­‰å€¼çº¿ï¼‰çš„è¾¹ç•Œã€‚(e)ï¼ˆå‡è®¾è¿™é‡Œå®é™…æ˜¯(f)ï¼‰è‚¿ç˜¤å¤å‘æƒ…å†µï¼Œä¸æ”¾ç–—è‚¿ç˜¤å­¦ç»„è§„å®šçš„ä¸´åºŠé¶åŒºï¼ˆCTV({RTOG})ï¼Œç»¿è‰²ï¼‰å’Œç‰¹å®šä¸´åºŠé¶åŒºï¼ˆCTV(P)ï¼Œè“è‰²ï¼‰çš„è¾¹ç•Œè¿›è¡Œæ¯”è¾ƒã€‚(f)ï¼ˆå‡è®¾è¿™é‡Œå®é™…æ˜¯(g)ï¼‰ç‰¹å®šä¸´åºŠé¶åŒºï¼ˆCTV(P)ï¼‰å’Œå…¨è‚¿ç˜¤åˆ†å‰²é˜ˆå€¼å¯¹åº”çš„(u{WcT})ç­‰å€¼é¢çš„ä¸‰ç»´é‡å»ºå›¾ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/e460a86fa9aebebde3b9c09a22f84fd1.png)

*Fig. I.18. Parameter Estimation Results for Patients Q1â€“Q8 using FET+SEG. Results with SEG is shown in Fig. I.18.*

å›¾I.18ï¼šä½¿ç”¨FET+SEGæ–¹æ³•å¾—åˆ°çš„æ‚£è€…Q1è‡³Q8çš„å‚æ•°ä¼°è®¡ç»“æœã€‚ä½¿ç”¨SEGæ–¹æ³•å¾—åˆ°çš„ç»“æœè§å›¾I.18

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/8f1b683ccb9c77e0283bcef2e1a9b84d.png)

*Fig. I.19. Parameter Estimation Results for Patients Q9â€“Q16 using FET+SEG. Results with SEG is shown in Fig. 8.*

å›¾I.19ï¼šä½¿ç”¨FET+SEGæ–¹æ³•å¯¹æ‚£è€…Q9è‡³Q16è¿›è¡Œå‚æ•°ä¼°è®¡çš„ç»“æœã€‚ä½¿ç”¨SEGæ–¹æ³•çš„ç»“æœå¦‚å›¾8æ‰€ç¤ºã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/0d00ea4925b766648dc718396b578a53.png)

*Fig. I.20. Recurrent tumors from patients Q1â€“Q3 and PDE model predictions usingSEG, as supplement to Fig. 9.*

å›¾I.20ï¼šæ‚£è€…Q1è‡³Q3çš„å¤å‘æ€§è‚¿ç˜¤æƒ…å†µï¼Œä»¥åŠä½¿ç”¨SEGæ•°æ®çš„åå¾®åˆ†æ–¹ç¨‹ï¼ˆPDEï¼‰æ¨¡å‹é¢„æµ‹ç»“æœï¼Œä½œä¸ºå¯¹å›¾9çš„è¡¥å……å†…å®¹ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/0eaa36e1a5bc240d2f0b897b891b40e9.png)

*Fig. I.21. Comparison of RTOG CTV (green) with Personalized CTV FET+SEG (blue)for patient Q13 over (A) pre-operative tumor and (B) recurrent tumor. Overlap ofinferred segmentations ğ‘¢ W ğ‘ T (yellow line) and ğ‘¢ TC ğ‘ (red line) on actual segmentations:WT (beige fill) and TC (pink fill); Margins for CTV RTOG (green) and CTV P (blue)*

å›¾I.21ï¼šå¯¹äºæ‚£è€…Q13ï¼Œæ”¾ç–—è‚¿ç˜¤å­¦ç»„ï¼ˆRTOGï¼‰æ‰€è§„å®šçš„ä¸´åºŠé¶åŒºï¼ˆCTVï¼Œç»¿è‰²ï¼‰ä¸ä½¿ç”¨FET+SEGæ–¹æ³•å¾—åˆ°çš„ä¸ªæ€§åŒ–ä¸´åºŠé¶åŒºï¼ˆCTVï¼Œè“è‰²ï¼‰çš„æ¯”è¾ƒï¼Œåˆ†åˆ«é’ˆå¯¹ï¼ˆAï¼‰æœ¯å‰è‚¿ç˜¤å’Œï¼ˆBï¼‰å¤å‘æ€§è‚¿ç˜¤ã€‚æ¨æ–­å‡ºçš„åˆ†å‰²åŒºåŸŸï¼Œå³å…¨è‚¿ç˜¤åˆ†å‰²é˜ˆå€¼å¯¹åº”çš„(u{WcT})ï¼ˆé»„çº¿ï¼‰å’Œè‚¿ç˜¤æ ¸å¿ƒåˆ†å‰²é˜ˆå€¼å¯¹åº”çš„(u{TCc})ï¼ˆçº¢çº¿ï¼‰ï¼Œä¸å®é™…åˆ†å‰²åŒºåŸŸçš„é‡å æƒ…å†µï¼šå…¨è‚¿ç˜¤ï¼ˆWTï¼Œæµ…è¤è‰²å¡«å……ï¼‰å’Œè‚¿ç˜¤æ ¸å¿ƒï¼ˆTCï¼Œç²‰çº¢è‰²å¡«å……ï¼‰ï¼›æ”¾ç–—è‚¿ç˜¤å­¦ç»„è§„å®šçš„ä¸´åºŠé¶åŒºï¼ˆCTV({RTOG})ï¼Œç»¿è‰²ï¼‰å’Œä¸ªæ€§åŒ–ä¸´åºŠé¶åŒºï¼ˆCTV(P)ï¼Œè“è‰²ï¼‰çš„è¾¹ç•Œã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/89dc04033dd784f7a73dedec7b2e752f.png)

*Fig. J.22. Box plot of the estimated tumor growth parameters ğœ‡îˆ°îˆ°âˆ•0.1 and ğœ‡îˆ¾îˆ¾âˆ•10for all 24 patients, including the characteristic parameters (labeled as Char) and thefinal parameters after fine-tuning with SEG and FET+SEG data.*

å›¾J.22ï¼šæ‰€æœ‰24ä½æ‚£è€…çš„ä¼°è®¡è‚¿ç˜¤ç”Ÿé•¿å‚æ•°(\mu{\mathcal{D}\mathcal{D}}/0.1)å’Œ(\mu{\mathcal{R}\mathcal{R}}/10)çš„ç®±çº¿å›¾ï¼Œå…¶ä¸­åŒ…æ‹¬ç‰¹å¾å‚æ•°ï¼ˆæ ‡è®°ä¸ºâ€œCharâ€ï¼‰ï¼Œä»¥åŠä½¿ç”¨SEGæ•°æ®å’ŒFET+SEGæ•°æ®è¿›è¡Œå¾®è°ƒåçš„æœ€ç»ˆå‚æ•°ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/d35c2aa2d74510b5fff66e45612f2394.png)

*Fig. J.23. Box plot of tumor core (TC) and whole tumor (WT) DICE scores andcorrelation with FET signal for all 24 patients using the characteristic solution (labeledas Char), or the solution after fine-tuning with SEG with FET+SEG data.*

å›¾J.23ï¼šæ‰€æœ‰24åæ‚£è€…çš„è‚¿ç˜¤æ ¸å¿ƒï¼ˆTCï¼‰å’Œå…¨è‚¿ç˜¤ï¼ˆWTï¼‰çš„DICEç³»æ•°ï¼Œä»¥åŠä¸æ°Ÿä¹™åŸºé…ªæ°¨é…¸ï¼ˆFETï¼‰ä¿¡å·çš„ç›¸å…³æ€§çš„ç®±çº¿å›¾ã€‚æ•°æ®åˆ†åˆ«åŸºäºç‰¹å¾è§£ï¼ˆæ ‡è®°ä¸ºâ€œCharâ€ï¼‰ï¼Œæˆ–è€…æ˜¯ä½¿ç”¨SEGæ•°æ®ä»¥åŠFET+SEGæ•°æ®è¿›è¡Œå¾®è°ƒåçš„è§£ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/dfd1f79658a3b3a60703f24afb9ffa29.png)

Fig. K.24. Correlation between FET signal and solidity of the FET region. Thecorrelation is 0.757 with ğ‘-value 1.8eâˆ’5. Ring-like FET signals has solidity valueslower than 1, indicative of a central void, and is related to lower correlation betweenpredicted cell densities and FET signals.

å›¾ K.24ï¼šæ°Ÿä¹™åŸºé…ªæ°¨é…¸ï¼ˆFETï¼‰ä¿¡å·ä¸ FET åŒºåŸŸå¯†å®åº¦ä¹‹é—´çš„ç›¸å…³æ€§ã€‚ç›¸å…³æ€§ä¸º 0.757ï¼Œpå€¼ä¸º1.8Ã—10âˆ’5 ã€‚ç¯çŠ¶çš„ FET ä¿¡å·çš„å¯†å®åº¦å€¼ä½äº 1ï¼Œè¿™è¡¨æ˜å­˜åœ¨ä¸­å¿ƒç©ºéš™ï¼Œå¹¶ä¸”ä¸é¢„æµ‹çš„ç»†èƒå¯†åº¦å’Œ FET ä¿¡å·ä¹‹é—´è¾ƒä½çš„ç›¸å…³æ€§æœ‰å…³ã€‚

**Table**

**è¡¨**

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/cfef11c191b6b16f7a40cf324ba13a14.png)

*Table 1Average and standard deviation of DICE scores and correlation with FET signal for all24 patients using characteristic parameters, or parameters obtained by fine-tuning withSEG with FET+SEG data. Fine-Tuning leads to better results.*

è¡¨1ï¼šä½¿ç”¨ç‰¹å¾å‚æ•°ï¼Œæˆ–ä½¿ç”¨é€šè¿‡å¯¹SEGæ•°æ®ä»¥åŠFET+SEGæ•°æ®è¿›è¡Œå¾®è°ƒæ‰€å¾—åˆ°çš„å‚æ•°ï¼Œè®¡ç®—å‡ºçš„æ‰€æœ‰24åæ‚£è€…çš„DICEç³»æ•°å¹³å‡å€¼å’Œæ ‡å‡†å·®ï¼Œä»¥åŠä¸FETä¿¡å·çš„ç›¸å…³æ€§ã€‚å¾®è°ƒå¯å¾—å‡ºæ›´å¥½çš„ç»“æœã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/c62afa89bd4d3ecdb405b2146a8bfe6d.png)

*Table 2Comparison of RTOG CTVs with personalized CTVs (1% isosurface of predicted tumor cell density) from different parameter estimation methods: LipkovÃ¡et al. (2019), FET+SEG, and SEG: (a) Relative volume with respect to RTOG CTV. (b) Efficiency, the percentage of WT at the first detected recurrencethat is covered by the CTV, see Eq. (20). (c) Ratio of efficiency over relative volume. In general, the personalized CTVs from LipkovÃ¡ et al. (2019),FET+SEG, and SEG present reduced or similar irradiation volumes while maintaining efficiency comparable to RTOG CTV*

è¡¨2ï¼šæ”¾å°„æ²»ç–—è‚¿ç˜¤åä½œç»„ï¼ˆRTOGï¼‰çš„ä¸´åºŠé¶åŒºï¼ˆCTVï¼‰ä¸é€šè¿‡ä¸åŒå‚æ•°ä¼°è®¡æ–¹æ³•å¾—å‡ºçš„ä¸ªæ€§åŒ–ä¸´åºŠé¶åŒºï¼ˆé¢„æµ‹è‚¿ç˜¤ç»†èƒå¯†åº¦çš„1%ç­‰å€¼é¢ï¼‰çš„æ¯”è¾ƒï¼šLipkovÃ¡ç­‰äººï¼ˆ2019å¹´ï¼‰çš„æ–¹æ³•ã€FET+SEGæ–¹æ³•ä»¥åŠSEGæ–¹æ³•ï¼š(a) ç›¸å¯¹äºRTOGçš„CTVçš„ç›¸å¯¹ä½“ç§¯ã€‚(b) æœ‰æ•ˆæ€§ï¼Œå³é¦–æ¬¡æ£€æµ‹åˆ°å¤å‘æ—¶è¢«CTVè¦†ç›–çš„å…¨è‚¿ç˜¤ï¼ˆWTï¼‰çš„ç™¾åˆ†æ¯”ï¼Œè§å…¬å¼(20)ã€‚(c) æœ‰æ•ˆæ€§ä¸ç›¸å¯¹ä½“ç§¯çš„æ¯”å€¼ã€‚æ€»ä½“è€Œè¨€ï¼ŒLipkovÃ¡ç­‰äººï¼ˆ2019å¹´ï¼‰çš„æ–¹æ³•ã€FET+SEGæ–¹æ³•ä»¥åŠSEGæ–¹æ³•å¾—å‡ºçš„ä¸ªæ€§åŒ–CTVï¼Œåœ¨ä¿æŒä¸RTOGçš„CTVç›¸å½“çš„æœ‰æ•ˆæ€§çš„åŒæ—¶ï¼Œå…¶ç…§å°„ä½“ç§¯æœ‰æ‰€å‡å°‘æˆ–ç›¸è¿‘ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/50d74e4a51c20317870936a38c625e96.png)

*Table A.3Comparison of the performance metrics for heterogeneous (ğ‘ = 10) and homogeneous (ğ‘ = 1) diffusionmodels using SEG data for patients P1â€“P8. Metrics include DICE scores for total contrast-enhancing tumor(DICETC) and white matter (DICEWT), correlation with FET signal (corrFET), and efficiency-to-volume ratio(Eff/Vol) for recurrent tumors*

è¡¨A.3ï¼šé’ˆå¯¹æ‚£è€…P1è‡³P8ï¼Œä½¿ç”¨SEGæ•°æ®ï¼Œå¯¹éå‡åŒ€æ‰©æ•£æ¨¡å‹ï¼ˆ(c = 10)ï¼‰å’Œå‡åŒ€æ‰©æ•£æ¨¡å‹ï¼ˆ(c = 1)ï¼‰çš„æ€§èƒ½æŒ‡æ ‡è¿›è¡Œæ¯”è¾ƒã€‚æŒ‡æ ‡åŒ…æ‹¬æ€»å¯¹æ¯”å¢å¼ºè‚¿ç˜¤çš„DICEç³»æ•°ï¼ˆ(DICE{TC})ï¼‰å’Œç™½è´¨çš„DICEç³»æ•°ï¼ˆ(DICE{WT})ï¼‰ã€ä¸æ°Ÿä¹™åŸºé…ªæ°¨é…¸ï¼ˆFETï¼‰ä¿¡å·çš„ç›¸å…³æ€§ï¼ˆ(corr_{FET})ï¼‰ï¼Œä»¥åŠå¤å‘æ€§è‚¿ç˜¤çš„æœ‰æ•ˆæ€§ä¸ä½“ç§¯æ¯”ï¼ˆ(Eff/Vol)ï¼‰ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/63af57ae7ea21425da8170cb712d03dd.png)

*Table B.4Mean and standard deviation of DICE scores for the tumor core (TC) and whole tumor (WT) regions, alongwith the correlation with the FET signal, for a*

è¡¨B.4ï¼šå¯¹äºæŸ[å…·ä½“å¯¹è±¡ï¼ŒåŸæ–‡æ­¤å¤„ç¼ºå¤±]ï¼Œè‚¿ç˜¤æ ¸å¿ƒï¼ˆTCï¼‰åŒºåŸŸå’Œå…¨è‚¿ç˜¤ï¼ˆWTï¼‰åŒºåŸŸçš„DICEç³»æ•°çš„å¹³å‡å€¼å’Œæ ‡å‡†å·®ï¼Œä»¥åŠè¿™äº›åŒºåŸŸä¸æ°Ÿä¹™åŸºé…ªæ°¨é…¸ï¼ˆFETï¼‰ä¿¡å·çš„ç›¸å…³æ€§ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/0ac74a534bf071aeb84a746ed0f9425c.png)

*Table C.5Characteristic parameter estimation from synthetic data. Datasets S1, S3, S5, and S8 use ğ±0 = (164, 116, 99) while S2, S4, S6, andS7 use ğ±0 = (65, 70, 99). For this synthetic data, the estimated values for ğœ‡îˆ° and ğœ‡îˆ¾ are near 1, which is the targeted outcome.*

è¡¨C.5ï¼šä»åˆæˆæ•°æ®ä¸­è¿›è¡Œçš„ç‰¹å¾å‚æ•°ä¼°è®¡ã€‚æ•°æ®é›†S1ã€S3ã€S5å’ŒS8ä½¿ç”¨(\mathbf{x}0 = (164, 116, 99))ï¼Œè€Œæ•°æ®é›†S2ã€S4ã€S6å’ŒS7ä½¿ç”¨(\mathbf{x}0 = (65, 70, 99))ã€‚å¯¹äºè¿™äº›åˆæˆæ•°æ®ï¼Œ(\mu{\mathcal{D}})å’Œ(\mu{\mathcal{R}})çš„ä¼°è®¡å€¼æ¥è¿‘1ï¼Œè¿™æ­£æ˜¯é¢„æœŸçš„ç»“æœã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/31eb0371191609f0a7b2ee336a5175d9.png)

*Table C.6Characteristic parameter estimation for patients P1â€“P8. Parameters ğ·, ğœŒ, and ğ‘¡ end are from LipkovÃ¡ et al. (2019) and used to computeğœ‡*îˆ° and ğœ‡îˆ¾*

è¡¨C.6ï¼šé’ˆå¯¹æ‚£è€…P1è‡³P8çš„ç‰¹å¾å‚æ•°ä¼°è®¡ã€‚å‚æ•°(D)ã€(\rho)ä»¥åŠ(t{end})æºè‡ªLipkovÃ¡ç­‰äººï¼ˆ2019å¹´ï¼‰çš„ç ”ç©¶ï¼Œå¹¶ç”¨äºè®¡ç®—(\mu{\mathcal{D}})å’Œ(\mu_{\mathcal{R}}) ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/436680850cc708d5698d038516224246.png)

*Table C.7Characteristic parameter estimation for patients Q1â€“Q16*

è¡¨C.7ï¼šé’ˆå¯¹æ‚£è€…Q1è‡³Q16çš„ç‰¹å¾å‚æ•°ä¼°è®¡ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/fcfd760cdfa47e995a701c20d8f1cb46.png)

*Table D.8Baseline and perturbed simulation results for patient P5, showing characteristic parameters, predicted modelparameters, and DICE scores with mean and standard deviation for the perturbed case.*

è¡¨D.8ï¼šæ‚£è€…P5çš„åŸºçº¿æ¨¡æ‹Ÿç»“æœå’Œæ‰°åŠ¨æ¨¡æ‹Ÿç»“æœï¼Œå±•ç¤ºäº†ç‰¹å¾å‚æ•°ã€é¢„æµ‹çš„æ¨¡å‹å‚æ•°ï¼Œä»¥åŠåœ¨æ‰°åŠ¨æƒ…å†µä¸‹DICEç³»æ•°çš„å‡å€¼å’Œæ ‡å‡†å·®ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/f78fc2bce544f10fd39a9ea047a768e1.png)

*Table G.9Estimated parameters from the synthetic dataset using SEG and FET+SEG, compared with ground truth(GT) values.*

è¡¨G.9ï¼šä½¿ç”¨SEGä»¥åŠFET+SEGæ–¹æ³•ï¼Œä»åˆæˆæ•°æ®é›†ä¸­ä¼°è®¡å‡ºçš„å‚æ•°ï¼Œå¹¶ä¸çœŸå®å€¼ï¼ˆGTï¼‰è¿›è¡Œäº†æ¯”è¾ƒã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/c53340d7f47f875cd60c6269c59e7706.png)

*Table H.10Statistics of absolute relative error (%) for ğœ‡îˆ° and ğœ‡îˆ¾ in the synthetic dataset (S1â€“S8) using varied datalosses for fine-tuning. u-t-all uses the ground truth cell density at residual collocation points over times in[0, 1], while u-t-end uses ground truth cell density at data collocation points at time 1. FET+SEG uses noisysegmentation and PET data. SEG uses noisy segmentation data only*

è¡¨H.10ï¼šåœ¨åˆæˆæ•°æ®é›†ï¼ˆS1è‡³S8ï¼‰ä¸­ï¼Œé’ˆå¯¹(\mu{\mathcal{D}})å’Œ(\mu{\mathcal{R}})ï¼Œä½¿ç”¨ä¸åŒçš„æ•°æ®æŸå¤±è¿›è¡Œå¾®è°ƒæ—¶çš„ç»å¯¹ç›¸å¯¹è¯¯å·®ï¼ˆ%ï¼‰ç»Ÿè®¡æ•°æ®ã€‚â€œu-t-allâ€ä½¿ç”¨åœ¨æ—¶é—´åŒºé—´([0, 1])å†…æ®‹å·®é…ç½®ç‚¹å¤„çš„çœŸå®ç»†èƒå¯†åº¦ï¼Œè€Œâ€œu-t-endâ€ä½¿ç”¨åœ¨æ—¶é—´ä¸º1æ—¶æ•°æ®é…ç½®ç‚¹å¤„çš„çœŸå®ç»†èƒå¯†åº¦ã€‚â€œFET + SEGâ€ä½¿ç”¨å«å™ªå£°çš„åˆ†å‰²æ•°æ®å’Œæ­£ç”µå­å‘å°„æ–­å±‚æ‰«æï¼ˆPETï¼‰æ•°æ®ã€‚â€œSEGâ€ä»…ä½¿ç”¨å«å™ªå£°çš„åˆ†å‰²æ•°æ®

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/d5bb275d72a26265c88d70aa0a2de0d7.png)

*Table I.11Average and standard deviation of DICE scores and correlation with FET signals for all24 patients using ğ‘¢ ğ‘ƒ ğ¼ğ‘ğ‘ . The metrics are in general better than those using ğ‘¢ ğ¹ğ·ğ‘€ (inTable 1), because ğ‘¢ ğ‘ƒ ğ¼ğ‘ğ‘ might sacrifice fidelity to the PDE to fit the data*

è¡¨I.11ï¼šä½¿ç”¨(u{PINN})æ—¶ï¼Œæ‰€æœ‰24åæ‚£è€…çš„DICEç³»æ•°çš„å¹³å‡å€¼å’Œæ ‡å‡†å·®ï¼Œä»¥åŠä¸æ°Ÿä¹™åŸºé…ªæ°¨é…¸ï¼ˆFETï¼‰ä¿¡å·çš„ç›¸å…³æ€§ã€‚æ€»ä½“è€Œè¨€ï¼Œè¿™äº›æŒ‡æ ‡ä¼˜äºä½¿ç”¨(u{FDM})æ—¶çš„æŒ‡æ ‡ï¼ˆè§è¡¨1ï¼‰ï¼Œè¿™æ˜¯å› ä¸º(u_{PINN})å¯èƒ½ä¼šä¸ºäº†æ‹Ÿåˆæ•°æ®è€Œç‰ºç‰²å¯¹åå¾®åˆ†æ–¹ç¨‹ï¼ˆPDEï¼‰çš„ä¿çœŸåº¦ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/61e0d96bc60b55fe3da18e986c180d0d.png)

*Table I.12Parameters estimated for patients P1â€“P8 using FET+SEG and SEG data, compared with results from LipkovÃ¡ et al. (2019)(âˆ— ).Parameters that are not included in the model are marked with â€˜â€˜â€“â€™â€™. Metrics include DICE score for both WT and TCsegmentations, as well as correlation with the FET signal (see Appendix I)*

è¡¨I.12ï¼šä½¿ç”¨FET+SEGæ•°æ®å’ŒSEGæ•°æ®ï¼Œå¯¹æ‚£è€…P1è‡³P8ä¼°è®¡å‡ºçš„å‚æ•°ï¼Œå¹¶ä¸LipkovÃ¡ç­‰äººï¼ˆ2019å¹´ï¼‰çš„ç»“æœï¼ˆâˆ—ï¼‰è¿›è¡Œæ¯”è¾ƒã€‚æœªåŒ…å«åœ¨æ¨¡å‹ä¸­çš„å‚æ•°ç”¨â€œâ€“â€æ ‡è®°ã€‚æŒ‡æ ‡åŒ…æ‹¬å…¨è‚¿ç˜¤ï¼ˆWTï¼‰å’Œè‚¿ç˜¤æ ¸å¿ƒï¼ˆTCï¼‰åˆ†å‰²çš„DICEç³»æ•°ï¼Œä»¥åŠä¸æ°Ÿä¹™åŸºé…ªæ°¨é…¸ï¼ˆFETï¼‰ä¿¡å·çš„ç›¸å…³æ€§ï¼ˆè§é™„å½•Iï¼‰ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/4ee84100affd28575d3b518b4bf096da.png)

*Table I.13Metrics for results using the characteristic parameters without fine-tuning. For all cases, ğœ‡îˆ° = ğœ‡îˆ¾ = 1,ğ‘š* = 1, ğ´ = 0, ğ‘¢ TC ğ‘ = 0.6, ğ‘¢ W ğ‘ T = 0.35. Without finetuning, the metrics are not as good as the resultsin Table I.12.*

è¡¨I.13ï¼šä½¿ç”¨æœªç»å¾®è°ƒçš„ç‰¹å¾å‚æ•°æ‰€å¾—ç»“æœçš„å„é¡¹æŒ‡æ ‡ã€‚åœ¨æ‰€æœ‰æƒ…å†µä¸­ï¼Œ(\mu{\mathcal{D}} = \mu{\mathcal{R}} = 1)ï¼Œ(m = 1)ï¼Œ(A = 0)ï¼Œ(u{TCc}= 0.6)ï¼Œ(u{WcT}= 0.35)ã€‚åœ¨æœªè¿›è¡Œå¾®è°ƒçš„æƒ…å†µä¸‹ï¼Œè¿™äº›æŒ‡æ ‡ä¸å¦‚è¡¨I.12ä¸­çš„ç»“æœç†æƒ³ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/ffc73dfc8c671df737c85e6514e44326.png)

*Table I.14Estimated parameters and metrics for Patients Q1â€“Q16, comparison between results using SEG and FET+SEGdata*

è¡¨I.14ï¼šæ‚£è€…Q1è‡³Q16çš„ä¼°è®¡å‚æ•°å’ŒæŒ‡æ ‡ï¼Œå¯¹ä½¿ç”¨SEGæ•°æ®å’ŒFET+SEGæ•°æ®æ‰€å¾—ç»“æœçš„æ¯”è¾ƒã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/d09d2e584fa14c930c02ec5ac160cf4c.png)

*Table I.15Comparison of RTOG CTVs with personalized CTVs (1% isosurface of predicted tumor cell density) from FET+SEG and SEG for Q1â€“Q13. (a)Relative volume with respect to RTOG CTV. (b) Efficiency, the percentage of TC at the first detected recurrence that is covered by the CTV(see text). (c) Ratio of efficiency over relative volume. In general, the personalized CTVs from FET+SEG and SEG present reduced or similarirradiation volumes while maintaining efficiency comparable to RTOG CTV.*

è¡¨I.15ï¼šå¯¹äºæ‚£è€…Q1è‡³Q13ï¼Œæ”¾ç–—è‚¿ç˜¤å­¦ç»„ï¼ˆRTOGï¼‰æ‰€è§„å®šçš„ä¸´åºŠé¶åŒºï¼ˆCTVï¼‰ï¼Œä¸ä½¿ç”¨FET+SEGä»¥åŠSEGæ–¹æ³•å¾—åˆ°çš„ä¸ªæ€§åŒ–ä¸´åºŠé¶åŒºï¼ˆé¢„æµ‹è‚¿ç˜¤ç»†èƒå¯†åº¦çš„1%ç­‰å€¼é¢ï¼‰çš„æ¯”è¾ƒã€‚(a) ç›¸å¯¹äºæ”¾ç–—è‚¿ç˜¤å­¦ç»„ï¼ˆRTOGï¼‰æ‰€è§„å®šä¸´åºŠé¶åŒºï¼ˆCTVï¼‰çš„ç›¸å¯¹ä½“ç§¯ã€‚(b) æ•ˆç‡ï¼Œå³é¦–æ¬¡æ£€æµ‹åˆ°çš„å¤å‘è‚¿ç˜¤ä¸­è¢«ä¸´åºŠé¶åŒºï¼ˆCTVï¼‰è¦†ç›–çš„è‚¿ç˜¤æ ¸å¿ƒï¼ˆTCï¼‰çš„ç™¾åˆ†æ¯”ï¼ˆè¯¦è§æ­£æ–‡ï¼‰ã€‚(c) æ•ˆç‡ä¸ç›¸å¯¹ä½“ç§¯çš„æ¯”å€¼ã€‚æ€»ä½“è€Œè¨€ï¼Œä½¿ç”¨FET+SEGå’ŒSEGæ–¹æ³•å¾—åˆ°çš„ä¸ªæ€§åŒ–ä¸´åºŠé¶åŒºï¼ˆCTVï¼‰ï¼Œåœ¨ä¿æŒä¸æ”¾ç–—è‚¿ç˜¤å­¦ç»„ï¼ˆRTOGï¼‰æ‰€è§„å®šä¸´åºŠé¶åŒºï¼ˆCTVï¼‰ç›¸å½“çš„æ•ˆç‡çš„åŒæ—¶ï¼Œå‘ˆç°å‡ºç…§å°„ä½“ç§¯å‡å°‘æˆ–ç›¸è¿‘çš„æƒ…å†µã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/e3c8f1640dc4d7d977294964fcdac542.png)

*Table J.16Paired t-test p-values for the comparison of the estimated parameters and metrics for synthetic (S1â€“S8) and patient data(P1â€“P8 and Q1â€“Q16) using different methods*

è¡¨J.16ï¼šä½¿ç”¨ä¸åŒæ–¹æ³•å¯¹åˆæˆæ•°æ®ï¼ˆS1è‡³S8ï¼‰ä»¥åŠæ‚£è€…æ•°æ®ï¼ˆP1è‡³P8å’ŒQ1è‡³Q16ï¼‰çš„ä¼°è®¡å‚æ•°å’ŒæŒ‡æ ‡è¿›è¡Œæ¯”è¾ƒæ—¶çš„é…å¯¹tæ£€éªŒ(p)å€¼ã€‚

![å›¾ç‰‡](https://i-blog.csdnimg.cn/img_convert/e7f40f8c5c29a8ffb9c08377ce10b542.png)

*Table L.17Percentage relative error of estimated parameters and the metrics, comparing effect of personalized pre-training (labeled S[1256])and fixed pre-training based on pre-trained model using characteristic parameter of S7 (labeled S[1256]âˆ— ). Personalized characteristicparameters give better results.*

è¡¨L.17ï¼šä¼°è®¡å‚æ•°çš„ç›¸å¯¹è¯¯å·®ç™¾åˆ†æ¯”ä»¥åŠå„é¡¹æŒ‡æ ‡ï¼Œæ¯”è¾ƒäº†ä¸ªæ€§åŒ–é¢„è®­ç»ƒï¼ˆæ ‡è®°ä¸ºS[1256]ï¼‰å’ŒåŸºäºä½¿ç”¨S7ç‰¹å¾å‚æ•°çš„é¢„è®­ç»ƒæ¨¡å‹çš„å›ºå®šé¢„è®­ç»ƒï¼ˆæ ‡è®°ä¸ºS[1256] ï¼‰çš„æ•ˆæœã€‚ä¸ªæ€§åŒ–ç‰¹å¾å‚æ•°èƒ½å¾—å‡ºæ›´å¥½çš„ç»“æœã€‚